<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE Publisher
  PUBLIC "-//Springer-Verlag//DTD A++ V2.4//EN" "http://devel.springer.de/A++/V2.4/DTD/A++V2.4.dtd">
<Publisher>
  <PublisherInfo>
    <PublisherName>Humana Press</PublisherName>
    <PublisherLocation>Totowa, NJ</PublisherLocation>
    <PublisherImprintName>Humana Press</PublisherImprintName>
  </PublisherInfo>
  <Series>
    <SeriesInfo SeriesType="Series" TocLevels="0">
      <SeriesID>7651</SeriesID>
      <SeriesPrintISSN>1064-3745</SeriesPrintISSN>
      <SeriesElectronicISSN>1940-6029</SeriesElectronicISSN>
      <SeriesTitle Language="En">Methods in Molecular Biology™</SeriesTitle>
      <SeriesSubTitle Language="En">Methods and Protocols</SeriesSubTitle>
      <SeriesAbbreviatedTitle>Methods Molecular Biology</SeriesAbbreviatedTitle>
    </SeriesInfo>
    <Book Language="En">
      <BookInfo BookProductType="Contributed volume" ContainsESM="No" Language="En" MediaType="eBook" NumberingStyle="ChapterContentSeparately" OutputMedium="All" TocLevels="0">
        <BookID>978-1-60327-931-4</BookID>
        <BookTitle>Neural Cell Transplantation</BookTitle>
        <BookSubTitle>Methods and Protocols</BookSubTitle>
        <BookVolumeNumber>549</BookVolumeNumber>
        <BookSequenceNumber>549</BookSequenceNumber>
        <BookDOI>10.1007/978-1-60327-931-4</BookDOI>
        <BookTitleID>160368</BookTitleID>
        <BookPrintISBN>978-1-60327-930-7</BookPrintISBN>
        <BookElectronicISBN>978-1-60327-931-4</BookElectronicISBN>
        <BookEdition>1</BookEdition>
        <BookChapterCount>16</BookChapterCount>
        <BookCopyright>
          <CopyrightHolderName>Humana Press</CopyrightHolderName>
          <CopyrightYear>2009</CopyrightYear>
        </BookCopyright>
        <BookSubjectGroup>
          <BookSubject Code="L" Type="Primary">Life Sciences</BookSubject>
          <BookSubject Code="L16008" Priority="1" Type="Secondary">Cell Biology</BookSubject>
          <BookSubject Code="L16010" Priority="2" Type="Secondary">Stem Cells</BookSubject>
          <SubjectCollection Code="SUCO11642">Biomedical and Life Sciences</SubjectCollection>
        </BookSubjectGroup>
        <BookContext>
          <SeriesID>7651</SeriesID>
        </BookContext>
      </BookInfo>
      <BookHeader>
        <EditorGroup>
          <Editor>
            <EditorName DisplayOrder="Western">
              <GivenName>David</GivenName>
              <FamilyName>Gordon</FamilyName>
            </EditorName>
            <Contact>
              <Email>d.gordon@bristol.ac.uk</Email>
            </Contact>
          </Editor>
          <Editor>
            <EditorName DisplayOrder="Western">
              <GivenName>Neil J.</GivenName>
              <FamilyName>Scolding</FamilyName>
            </EditorName>
            <Contact>
              <Phone>+440177918-6632</Phone>
              <Email>n.j.scolding@tesco.net</Email>
            </Contact>
          </Editor>
          <Affiliation ID="AffID1">
            <OrgDivision>Frenchay Hospital</OrgDivision>
            <OrgName>University of Bristol</OrgName>
            <OrgAddress>
              <City>Bristol</City>
              <Postcode>BS16 1LE</Postcode>
              <Country>United Kingdom</Country>
            </OrgAddress>
          </Affiliation>
          <Affiliation ID="AffID2">
            <OrgDivision>Frenchay Hospital</OrgDivision>
            <OrgName>University of Bristol</OrgName>
            <OrgAddress>
              <City>Bristol</City>
              <Postcode>BS16 1LE</Postcode>
              <Country>United Kingdom</Country>
            </OrgAddress>
          </Affiliation>
        </EditorGroup>
      </BookHeader>
      <Part ID="Part2">
        <PartInfo OutputMedium="All" TocLevels="0">
          <PartID>2</PartID>
          <PartSequenceNumber>2</PartSequenceNumber>
          <PartTitle> Practical/Methodological Chapters</PartTitle>
          <PartChapterCount>13</PartChapterCount>
          <PartContext>
            <SeriesID>7651</SeriesID>
            <BookID>978-1-60327-931-4</BookID>
            <BookTitle>Neural Cell Transplantation</BookTitle>
          </PartContext>
        </PartInfo>
        <Chapter ID="Chap5" Language="En">
          <ChapterInfo ChapterType="OriginalPaper" ContainsESM="No" Language="En" NumberingStyle="ChapterContentSeparately" OutputMedium="All" TocLevels="0">
            <ChapterID>5</ChapterID>
            <ChapterNumber>5</ChapterNumber>
            <ChapterDOI>10.1007/978-1-60327-931-4_5</ChapterDOI>
            <ChapterSequenceNumber>5</ChapterSequenceNumber>
            <ChapterTitle Language="En">Derivation of High-Purity Oligodendroglial Progenitors</ChapterTitle>
            <ChapterFirstPage>59</ChapterFirstPage>
            <ChapterLastPage>75</ChapterLastPage>
            <ChapterCopyright>
              <CopyrightHolderName>Humana Press, a part of Springer Science+Business Media, LLC</CopyrightHolderName>
              <CopyrightYear>2009</CopyrightYear>
            </ChapterCopyright>
            <ChapterHistory>
              <RegistrationDate>
                <Year>2009</Year>
                <Month>1</Month>
                <Day>5</Day>
              </RegistrationDate>
              <OnlineDate>
                <Year>2009</Year>
                <Month>3</Month>
                <Day>23</Day>
              </OnlineDate>
            </ChapterHistory>
            <ChapterGrants Type="Regular"><MetadataGrant Grant="OpenAccess"/><AbstractGrant Grant="OpenAccess"/><BodyPDFGrant Grant="Restricted"/><BodyHTMLGrant Grant="Restricted"/><BibliographyGrant Grant="Restricted"/><ESMGrant Grant="Restricted"/></ChapterGrants><ChapterContext>
              <SeriesID>7651</SeriesID>
              <PartID>2</PartID>
              <BookID>978-1-60327-931-4</BookID>
              <BookTitle>Neural Cell Transplantation</BookTitle>
            </ChapterContext>
          </ChapterInfo>
          <ChapterHeader>
            <AuthorGroup>
              <Author AffiliationIDS="Aff1_5">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Maya</GivenName>
                  <GivenName>N.</GivenName>
                  <FamilyName>Hatch</FamilyName>
                </AuthorName>
              </Author>
              <Author AffiliationIDS="Aff1_5">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Gabriel</GivenName>
                  <FamilyName>Nistor</FamilyName>
                </AuthorName>
              </Author>
              <Author AffiliationIDS="Aff1_5" CorrespondingAffiliationID="Aff1_5">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Hans</GivenName>
                  <GivenName>S.</GivenName>
                  <FamilyName>Keirstead</FamilyName>
                </AuthorName>
                <Contact>
                  <Email>hansk@uci.edu</Email>
                </Contact>
              </Author>
              <Affiliation ID="Aff1_5">
                <OrgDivision>Department of Anatomy and Neurobiology, Reeve-Irvine Research Center, 2111 Gillespie Neuroscience Research Facility, College of Medicine</OrgDivision>
                <OrgName>University of California at Irvine</OrgName>
                <OrgAddress>
                  <Postcode>92697-4292</Postcode>
                  <City>Irvine</City>
                  <State>CA</State>
                  <Country>USA</Country>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
            <Abstract ID="Abs1_5" Language="En" OutputMedium="All">
              <Heading>Summary</Heading>
              <Para>Oligodendrocytes are a type of glial cells that play a critical role in supporting the central nervous system (CNS), in particular insulating axons within the CNS by wrapping them with a myelin sheath, thereby enabling saltatory conduction. They are lost, and myelin damaged – demyelination – in a wide variety of neurological disorders. Replacing depleted cell types within demyelinated areas, however, has been shown experimentally to achieve remyelination and so help restore function. One method to produce oligodendrocytes for cellular replacement therapies is through the use of progenitor or stem cells. The ability to differentiate progenitor or stem cells into high-purity fates not only permits the generation of specific cells for transplantation therapies, but also provides powerful tools for studying cellular mechanisms of development. This chapter outlines methods of generating high-purity OPCs from multipotent neonatal progenitor or human embryonic stem cells.</Para>
            </Abstract>
            <KeywordGroup Language="En">
              <Heading>Key words:</Heading>
              <Keyword>High-purity oligodendrocyte precursor cultures</Keyword>
              <Keyword>Oligodendrocytes</Keyword>
              <Keyword>Remyelination</Keyword>
              <Keyword>Oligodendrocyte precursors</Keyword>
            </KeywordGroup>
          </ChapterHeader>
          <Body>
            <Section1 ID="Sec1_5">
              <Heading>Introduction</Heading>
              <Para>Oligodendrocytes are a type of glial cells that play a critical role in supporting the central nervous system (CNS). They insulate axons within the CNS by wrapping them with a myelin sheath, thereby enabling saltatory conduction. Demyelination refers to the loss of the myelin sheath, and characterizes a number of disorders including but not limited to spinal cord injury, multiple sclerosis, brain trauma, stroke, Alzheimer’s disease, adrenoleukodystrophy, Guillain–Barre syndrome, Canavan disease, post-infectious encephalitis, and chronic inflammatory polyneuropathies (<CitationRef CitationID="CR1_5">1</CitationRef>–<CitationRef CitationID="CR9_5">9</CitationRef>). In addition to a loss of saltatory conduction in axons, demyelination can also lead to axon degeneration and further disease progression (<CitationRef CitationID="CR7_5">7</CitationRef>, <CitationRef CitationID="CR10_5">10</CitationRef>–<CitationRef CitationID="CR12_5">12</CitationRef>) that cannot be rectified by the limited endogenous repair mechanisms (<CitationRef CitationID="CR13_5">13</CitationRef>–<CitationRef CitationID="CR19_5">19</CitationRef>).</Para>
              <Para>Remyelination refers to replacement of the myelin sheath, which can restore saltatory conduction (<CitationRef CitationID="CR20_5">20</CitationRef>, <CitationRef CitationID="CR21_5">21</CitationRef>), improve locomotor deficit (<CitationRef CitationID="CR22_5">22</CitationRef>–<CitationRef CitationID="CR24_5">24</CitationRef>), and prevent further axonal loss and disease progression by improving axonal integrity (<CitationRef CitationID="CR23_5">23</CitationRef>, <CitationRef CitationID="CR25_5">25</CitationRef>, <CitationRef CitationID="CR26_5">26</CitationRef>). Remyelination can be achieved by replacing depleted cell types within demyelinated areas, and has been demonstrated using oligodendrocyte precursor cells (OPCs), Schwann cells, and olfactory ensheathing glia (<CitationRef CitationID="CR27_5">27</CitationRef>–<CitationRef CitationID="CR33_5">33</CitationRef>).</Para>
              <Para>One method to produce OPCs for cellular replacement therapies is through the use of progenitor or stem cells. These OPC sources have been used in several animal models of demyelination, and have been shown to integrate, differentiate, and remyelinate damaged CNS (<CitationRef CitationID="CR23_5">23</CitationRef>, <CitationRef CitationID="CR34_5">34</CitationRef>–<CitationRef CitationID="CR39_5">39</CitationRef>). Derivation of high-purity OPC cultures is one of the major challenges facing the development of therapeutic strategies to address demyelination. This chapter outlines methods of generating high-purity OPCs from multipotent neonatal progenitor or human embryonic stem cells (hESCs). The ability to differentiate progenitor or stem cells into high-purity fates not only permits the generation of specific cells for transplantation therapies, but also provides powerful tools for studying cellular mechanisms of development.</Para>
            </Section1>
            <Section1 ID="Sec2_5">
              <Heading>Materials</Heading>
              <Section2 ID="Sec3_5">
                <Heading>OPC Generation from Neural Progenitor Cells</Heading>
                <Section3 ID="Sec4_5">
                  <Heading>Supplies</Heading>
                  <Para>
                    <OrderedList>
                      <ListItem>
                        <ItemNumber>1.</ItemNumber>
                        <ItemContent>
                          <Para>Low adherent 6-well plates (Corning, Cat #3471).</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>2.</ItemNumber>
                        <ItemContent>
                          <Para>50-ml centrifuge tubes (Fisher #: 05-538-68).</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>3.</ItemNumber>
                        <ItemContent>
                          <Para>1 l Vacuum Filters 0.22 μM polystyrene (Corning #: 431205).</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>4.</ItemNumber>
                        <ItemContent>
                          <Para>Permanox Lab-Tek™ Chamber Slides™ (Fisher #: 12-565-21).</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>5.</ItemNumber>
                        <ItemContent>
                          <Para>T75/75 cm<Superscript>2</Superscript> flasks (BD Biosciences #: 13-680-65).</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>6.</ItemNumber>
                        <ItemContent>
                          <Para>Trypan blue (Sigma #: T8154).</Para>
                        </ItemContent>
                      </ListItem>
                    </OrderedList>
                  </Para>
                </Section3>
                <Section3 ID="Sec5_5">
                  <Heading>Solutions</Heading>
                  <Para>
                    <OrderedList>
                      <ListItem>
                        <ItemNumber>1.</ItemNumber>
                        <ItemContent>
                          <Para>DMEM:F12 media (Gibco #: 10565-018).</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>2.</ItemNumber>
                        <ItemContent>
                          <Para>DMEM media (Gibco #: 12430-047).</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>3.</ItemNumber>
                        <ItemContent>
                          <Para>0.05% trypsin–EDTA (Gibco #: 25300-054).</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>4.</ItemNumber>
                        <ItemContent>
                          <Para>Antitrypsin (Sigma #: T7659).</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>5.</ItemNumber>
                        <ItemContent>
                          <Para>Poly-<Emphasis Type="SmallCaps">l</Emphasis>-lysine (Sigma #: P4707).
<UnorderedList Mark="Dash">
                              <ItemContent>
                                <Para>Laminin (Sigma #: L2020.</Para>
                              </ItemContent>
                            </UnorderedList>
                          </Para>
                        </ItemContent>
                      </ListItem>
                    </OrderedList>
                  </Para>
                </Section3>
                <Section3 ID="Sec6_5">
                  <Heading>Recipes</Heading>
                  <Section4 ID="Sec7_5">
                    <Heading>Oligodendrocyte Culture Media</Heading>
                    <Para>
                      <OrderedList>
                        <ListItem>
                          <ItemNumber>1.</ItemNumber>
                          <ItemContent>
                            <Para>1,000 ml of DMEM:F12 media.</Para>
                          </ItemContent>
                        </ListItem>
                        <ListItem>
                          <ItemNumber>2.</ItemNumber>
                          <ItemContent>
                            <Para>2 × 10 ml of 1:50 B27 supplement.</Para>
                          </ItemContent>
                        </ListItem>
                        <ListItem>
                          <ItemNumber>3.</ItemNumber>
                          <ItemContent>
                            <Para>Insulin (10 μg/ml).</Para>
                          </ItemContent>
                        </ListItem>
                        <ListItem>
                          <ItemNumber>4.</ItemNumber>
                          <ItemContent>
                            <Para>Progesterone (63 ng/ml).</Para>
                          </ItemContent>
                        </ListItem>
                        <ListItem>
                          <ItemNumber>5.</ItemNumber>
                          <ItemContent>
                            <Para>Putrescine (10 μg/ml).</Para>
                          </ItemContent>
                        </ListItem>
                        <ListItem>
                          <ItemNumber>6.</ItemNumber>
                          <ItemContent>
                            <Para>Sodium selenite (50 ng/ml).</Para>
                          </ItemContent>
                        </ListItem>
                        <ListItem>
                          <ItemNumber>7.</ItemNumber>
                          <ItemContent>
                            <Para>Transferrin (50 μg/ml).</Para>
                          </ItemContent>
                        </ListItem>
                        <ListItem>
                          <ItemNumber>8.</ItemNumber>
                          <ItemContent>
                            <Para>T3 (40 ng/ml).</Para>
                          </ItemContent>
                        </ListItem>
                      </OrderedList>
                    </Para>
                    <Para>Filter through 0.22 μm pore</Para>
                  </Section4>
                </Section3>
              </Section2>
              <Section2 ID="Sec8_5">
                <Heading>OPC Generation from Human Embryonic Stem Cells</Heading>
                <Section3 ID="Sec9_5">
                  <Heading>Supplies</Heading>
                  <Para>
                    <OrderedList>
                      <ListItem>
                        <ItemNumber>1.</ItemNumber>
                        <ItemContent>
                          <Para>15 ml conicals (Fisher #: 14-959-11B) and 50 ml conicals (Fisher #: 05-538-68).</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>2.</ItemNumber>
                        <ItemContent>
                          <Para>1.5 ml eppendorf tubes (Fisher Scientific #: 05-402-96).</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>3.</ItemNumber>
                        <ItemContent>
                          <Para>BD biosciences T75 and T150 cell culture flasks (Fisher #: 13-680-65 and 08-772-48).</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>4.</ItemNumber>
                        <ItemContent>
                          <Para>6-well Costar low attachment plates (Corning #: 3471).</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>5.</ItemNumber>
                        <ItemContent>
                          <Para>
                            <Emphasis Type="Italic">Barrier tips</Emphasis>. 200 μl and 1,000 μl (any vendor).</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>6.</ItemNumber>
                        <ItemContent>
                          <Para>1 l Vacuum Filters.22 μM polystyrene (Corning #: 431205).</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>7.</ItemNumber>
                        <ItemContent>
                          <Para>Permanox Lab-Tek™ Chamber Slides™ (Nunc #: 177437).</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>8.</ItemNumber>
                        <ItemContent>
                          <Para>Trypan blue (Sigma #: T8154).</Para>
                        </ItemContent>
                      </ListItem>
                    </OrderedList>
                  </Para>
                </Section3>
                <Section3 ID="Sec10_5">
                  <Heading>Stock Media/Solutions</Heading>
                  <Para>
                    <OrderedList>
                      <ListItem>
                        <ItemNumber>1.</ItemNumber>
                        <ItemContent>
                          <Para>70% ethanol.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>2.</ItemNumber>
                        <ItemContent>
                          <Para>30% Bleach.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>3.</ItemNumber>
                        <ItemContent>
                          <Para>DMEM:F12 media (Gibco #: 10565-018).</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>4.</ItemNumber>
                        <ItemContent>
                          <Para>KO-DMEM media (Gibco #: 10829-018).</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>5.</ItemNumber>
                        <ItemContent>
                          <Para>DMEM media (Gibco #: 12430-047).</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>6.</ItemNumber>
                        <ItemContent>
                          <Para>Water for embryo transfer (WET) (Sigma catalog #W1503).</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>7.</ItemNumber>
                        <ItemContent>
                          <Para>D-PBS (Gibco catalog #14190-144).</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>8.</ItemNumber>
                        <ItemContent>
                          <Para>0.05% Trypsin–EDTA (Gibco #: 25300-054).</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>9.</ItemNumber>
                        <ItemContent>
                          <Para>Trypsin inhibitor or antitrypsin (Sigma #: T7659).</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>10.</ItemNumber>
                        <ItemContent>
                          <Para>Bovine serum albumin (Sigma #: A2153).</Para>
                        </ItemContent>
                      </ListItem>
                    </OrderedList>
                  </Para>
                </Section3>
                <Section3 ID="Sec11_5">
                  <Heading>Supplements</Heading>
                  <Para>See <Emphasis Type="Bold">Table</Emphasis>
                    <InternalRef RefID="Tab1">1</InternalRef>. Supplements are prepared according to the manufacturer specification and stored in 1 ml aliquots at −20°C at 1,000× the stock concentration.<Table Float="Yes" ID="Tab1">
                      <Caption Language="En">
                        <CaptionNumber>Table 1</CaptionNumber>
                        <CaptionContent>
                          <SimplePara>Required supplements</SimplePara>
                        </CaptionContent>
                      </Caption>
                      <tgroup cols="5">
                        <colspec colname="c0" colnum="0"/>
                        <colspec colname="c1" colnum="1"/>
                        <colspec colname="c2" colnum="2"/>
                        <colspec colname="c3" colnum="3"/>
                        <colspec colname="c4" colnum="4"/>
                        <thead>
                          <row>
                            <entry colname="c0">
                              <SimplePara>Component</SimplePara>
                            </entry>
                            <entry colname="c1">
                              <SimplePara>Manufacturer (catalogue #)</SimplePara>
                            </entry>
                            <entry colname="c2">
                              <SimplePara>Stock concentration</SimplePara>
                            </entry>
                            <entry colname="c3">
                              <SimplePara>Final Concentration</SimplePara>
                            </entry>
                            <entry colname="c4">
                              <SimplePara>Dilution media</SimplePara>
                            </entry>
                          </row>
                        </thead>
                        <tbody>
                          <row>
                            <entry colname="c0">
                              <SimplePara>B27</SimplePara>
                            </entry>
                            <entry colname="c1">
                              <SimplePara>Gibco (17504-044)</SimplePara>
                            </entry>
                            <entry colname="c2">
                              <SimplePara>50×</SimplePara>
                            </entry>
                            <entry colname="c3">
                              <SimplePara>1:50</SimplePara>
                            </entry>
                            <entry colname="c4">
                              <SimplePara>n/a</SimplePara>
                            </entry>
                          </row>
                          <row>
                            <entry colname="c0">
                              <SimplePara>Insulin</SimplePara>
                            </entry>
                            <entry colname="c1">
                              <SimplePara>Sigma (I-1882)</SimplePara>
                            </entry>
                            <entry colname="c2">
                              <SimplePara>10 mg/ml</SimplePara>
                            </entry>
                            <entry colname="c3">
                              <SimplePara>10 μg/ml</SimplePara>
                            </entry>
                            <entry colname="c4">
                              <SimplePara>100 μl glacial acetic acid, rest w/WET</SimplePara>
                            </entry>
                          </row>
                          <row>
                            <entry colname="c0">
                              <SimplePara>Progesterone</SimplePara>
                            </entry>
                            <entry colname="c1">
                              <SimplePara>Sigma (P-6149)</SimplePara>
                            </entry>
                            <entry colname="c2">
                              <SimplePara>63 μg/ml</SimplePara>
                            </entry>
                            <entry colname="c3">
                              <SimplePara>63 ng/ml</SimplePara>
                            </entry>
                            <entry colname="c4">
                              <SimplePara>1 ml of EtOH then rest w/KO-DMEM</SimplePara>
                            </entry>
                          </row>
                          <row>
                            <entry colname="c0">
                              <SimplePara>Putrescine</SimplePara>
                            </entry>
                            <entry colname="c1">
                              <SimplePara>Sigma (P-6024)</SimplePara>
                            </entry>
                            <entry colname="c2">
                              <SimplePara>10 mg/ml</SimplePara>
                            </entry>
                            <entry colname="c3">
                              <SimplePara>10 μg/ml</SimplePara>
                            </entry>
                            <entry colname="c4">
                              <SimplePara>KO_DMEM</SimplePara>
                            </entry>
                          </row>
                          <row>
                            <entry colname="c0">
                              <SimplePara>Sodium selenite</SimplePara>
                            </entry>
                            <entry colname="c1">
                              <SimplePara>Sigma (S-9133)</SimplePara>
                            </entry>
                            <entry colname="c2">
                              <SimplePara>50 μg/ml</SimplePara>
                            </entry>
                            <entry colname="c3">
                              <SimplePara>50 ng/ml</SimplePara>
                            </entry>
                            <entry colname="c4">
                              <SimplePara>WET</SimplePara>
                            </entry>
                          </row>
                          <row>
                            <entry colname="c0">
                              <SimplePara>Transferrin</SimplePara>
                            </entry>
                            <entry colname="c1">
                              <SimplePara>Sigma (T-1408)</SimplePara>
                            </entry>
                            <entry colname="c2">
                              <SimplePara>50 mg/ml</SimplePara>
                            </entry>
                            <entry colname="c3">
                              <SimplePara>50 μg/ml</SimplePara>
                            </entry>
                            <entry colname="c4">
                              <SimplePara>KO-DMEM</SimplePara>
                            </entry>
                          </row>
                          <row>
                            <entry colname="c0">
                              <SimplePara>T3</SimplePara>
                            </entry>
                            <entry colname="c1">
                              <SimplePara>Sigma (T-5516)</SimplePara>
                            </entry>
                            <entry colname="c2">
                              <SimplePara>40 μg/ml</SimplePara>
                            </entry>
                            <entry colname="c3">
                              <SimplePara>40 ng/ml</SimplePara>
                            </entry>
                            <entry colname="c4">
                              <SimplePara>Add 1 ml of 1 N NaOH then KO-DMEM</SimplePara>
                            </entry>
                          </row>
                          <row>
                            <entry colname="c0">
                              <SimplePara>Collagenase IV</SimplePara>
                            </entry>
                            <entry colname="c1">
                              <SimplePara>Gibco (17101-015)</SimplePara>
                            </entry>
                            <entry colname="c2">
                              <SimplePara>1 mg/ml</SimplePara>
                            </entry>
                            <entry colname="c3">
                              <SimplePara>1 mg/ml</SimplePara>
                            </entry>
                            <entry colname="c4">
                              <SimplePara>–</SimplePara>
                            </entry>
                          </row>
                          <row>
                            <entry colname="c0">
                              <SimplePara>bFGF</SimplePara>
                            </entry>
                            <entry colname="c1">
                              <SimplePara>Gibco (13256-029)</SimplePara>
                            </entry>
                            <entry colname="c2">
                              <SimplePara>10 μg</SimplePara>
                            </entry>
                            <entry colname="c3">
                              <SimplePara>4 ng/ml</SimplePara>
                            </entry>
                            <entry colname="c4">
                              <SimplePara>0.5% BSA/PBS</SimplePara>
                            </entry>
                          </row>
                          <row>
                            <entry colname="c0">
                              <SimplePara>RA<Superscript>a</Superscript>
                              </SimplePara>
                            </entry>
                            <entry colname="c1">
                              <SimplePara>Sigma (R-2625)</SimplePara>
                            </entry>
                            <entry colname="c2">
                              <SimplePara>20 mM</SimplePara>
                            </entry>
                            <entry colname="c3">
                              <SimplePara>10 μM</SimplePara>
                            </entry>
                            <entry colname="c4">
                              <SimplePara>DMSO</SimplePara>
                            </entry>
                          </row>
                          <row>
                            <entry colname="c0">
                              <SimplePara>EGF</SimplePara>
                            </entry>
                            <entry colname="c1">
                              <SimplePara>Sigma (E-9644)</SimplePara>
                            </entry>
                            <entry colname="c2">
                              <SimplePara>20 μg/ml</SimplePara>
                            </entry>
                            <entry colname="c3">
                              <SimplePara>20 ng/ml</SimplePara>
                            </entry>
                            <entry colname="c4">
                              <SimplePara>KO-DMEM</SimplePara>
                            </entry>
                          </row>
                        </tbody>
                      </tgroup>
                      <tfooter>
                        <SimplePara>
                          <Superscript>a</Superscript> Add 1 ml of DMSO to the vial and swirl to dissolve. Transfer the solution to a 15 ml tube and wash the ampule with 200 μl of DMSO. Add DMSO to the final volume of 8.3 ml. Make 100–300 μl aliquots of this mixture in light protected vials and store at −80°C</SimplePara>
                      </tfooter>
                    </Table>
                  </Para>
                </Section3>
                <Section3 ID="Sec12_5">
                  <Heading>Recipes</Heading>
                  <Para>
                    <OrderedList>
                      <ListItem>
                        <ItemNumber>1.</ItemNumber>
                        <ItemContent>
                          <Para>Mouse embryonic feeder conditioned medium (MEF-CM) – see published protocols.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>2.</ItemNumber>
                        <ItemContent>
                          <Para>Glial restrictive media (GRM) for 1 l:
<UnorderedList Mark="Dash">
                              <ItemContent>
                                <Para>1,000 ml of DMEM:F12 media.</Para>
                              </ItemContent>
                              <ItemContent>
                                <Para>2 × 10 ml of 1:50 B27 supplement.</Para>
                              </ItemContent>
                              <ItemContent>
                                <Para>1 vial of stock insulin (10 μg/ml).</Para>
                              </ItemContent>
                              <ItemContent>
                                <Para>1 vial of stock progesterone (63 ng/ml).</Para>
                              </ItemContent>
                              <ItemContent>
                                <Para>1 vial of putrescine (10 μg/ml).</Para>
                              </ItemContent>
                              <ItemContent>
                                <Para>1 vial of sodium selenite (50ng/ml).</Para>
                              </ItemContent>
                              <ItemContent>
                                <Para>1 vial of transferrin (50 μg/ml).</Para>
                              </ItemContent>
                              <ItemContent>
                                <Para>1 vial of T3 (40 ng/ml).</Para>
                              </ItemContent>
                              <ItemContent>
                                <Para>Mix the components in a filter cup/bottle and vacuum filter. Homogenize by gently swirling the bottle. Avoid media on the bottle cap. Warm up only the required volume.</Para>
                              </ItemContent>
                            </UnorderedList>
                          </Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>3.</ItemNumber>
                        <ItemContent>
                          <Para>Transition medium (TR).
<UnorderedList Mark="Dash">
                              <ItemContent>
                                <Para>Made as a 1:1 mixture of GRM and MEF-CM.</Para>
                              </ItemContent>
                            </UnorderedList>
                          </Para>
                        </ItemContent>
                      </ListItem>
                    </OrderedList>
                  </Para>
                  <Para>Other solutions:
<OrderedList>
                      <ListItem>
                        <ItemNumber>4.</ItemNumber>
                        <ItemContent>
                          <Para>Matrigel coating 1:30. Matrigel will jellify instantly at room temperature. Manipulations after thawing have to be done quickly in precooled recipients on ice.
<UnorderedList Mark="Dash">
                              <ItemContent>
                                <Para>Obtain growth factor reduced Matrigel from BD Biosciences (Cat #356231). Place the bottle in a cold water bath and before complete thaw, open the cap and add 10 ml KO-DMEM. Dissolve the remaining frozen block by pipetting up and down (avoid foam formation) and quickly aliquot into 15 ml centrifuge tubes, 2 ml of 1:2 Matrigel in each. These aliquots have to be immediately frozen and kept at −20°C until needed.</Para>
                              </ItemContent>
                              <ItemContent>
                                <Para>To prepare the working solution, 8 ml of KO-DMEM is added to each 2 ml frozen aliquot for a total volume of 10 ml. For the final dilution, an additional 20 ml of KO-DMEM is added to each aliquot and then distributed into the flasks (for example 10 ml in each). Gently swirl the coating solution in the flask and place it in a 4°C refrigerator. The flasks are coated in approximately 3 h and can be used the same or next day.</Para>
                              </ItemContent>
                              <ItemContent>
                                <Para>One hour before use, the coating Matrigel solution is discarded from the flask and replaced with the working media formulation. The flask is placed in a CO<Subscript>2</Subscript> incubator for pH and temperature balance.</Para>
                              </ItemContent>
                            </UnorderedList>
                          </Para>
                        </ItemContent>
                      </ListItem>
                    </OrderedList>
                  </Para>
                </Section3>
              </Section2>
              <Section2 ID="Sec13_5">
                <Heading>Markers and Dilutions</Heading>
                <Para>
                  <Emphasis Type="Italic">see</Emphasis>
                  <Emphasis Type="Bold">Table</Emphasis>
                  <InternalRef RefID="Tab2">2</InternalRef>
                  <Table Float="Yes" ID="Tab2">
                    <Caption Language="En">
                      <CaptionNumber>Table 2</CaptionNumber>
                      <CaptionContent>
                        <SimplePara>Common antibodies used for ICC profiling to identify OPC cultures are listed in the table with their respective dilutions</SimplePara>
                      </CaptionContent>
                    </Caption>
                    <tgroup cols="3">
                      <colspec colname="c0" colnum="0"/>
                      <colspec colname="c1" colnum="1"/>
                      <colspec colname="c2" colnum="2"/>
                      <thead>
                        <row>
                          <entry colname="c0">
                            <SimplePara>Antibody</SimplePara>
                          </entry>
                          <entry colname="c1">
                            <SimplePara>Host</SimplePara>
                          </entry>
                          <entry colname="c2">
                            <SimplePara>Dilution</SimplePara>
                          </entry>
                        </row>
                      </thead>
                      <tbody>
                        <row>
                          <entry colname="c0">
                            <SimplePara>A2B5</SimplePara>
                          </entry>
                          <entry colname="c1">
                            <SimplePara>Mouse</SimplePara>
                          </entry>
                          <entry colname="c2">
                            <SimplePara>1:200</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry colname="c0">
                            <SimplePara>Pax 6</SimplePara>
                          </entry>
                          <entry colname="c1">
                            <SimplePara>Rabbit</SimplePara>
                          </entry>
                          <entry colname="c2">
                            <SimplePara>1:200</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry colname="c0">
                            <SimplePara>Olig1</SimplePara>
                          </entry>
                          <entry colname="c1">
                            <SimplePara>Rabbit</SimplePara>
                          </entry>
                          <entry colname="c2">
                            <SimplePara>1:200</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry colname="c0">
                            <SimplePara>Sox10</SimplePara>
                          </entry>
                          <entry colname="c1">
                            <SimplePara>Rabbit</SimplePara>
                          </entry>
                          <entry colname="c2">
                            <SimplePara>1:200</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry colname="c0">
                            <SimplePara>Nestin</SimplePara>
                          </entry>
                          <entry colname="c1">
                            <SimplePara>Mouse</SimplePara>
                          </entry>
                          <entry colname="c2">
                            <SimplePara>1:200</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry colname="c0">
                            <SimplePara>NG2</SimplePara>
                          </entry>
                          <entry colname="c1">
                            <SimplePara>Rabbit</SimplePara>
                          </entry>
                          <entry colname="c2">
                            <SimplePara>1:200</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry colname="c0">
                            <SimplePara>O4</SimplePara>
                          </entry>
                          <entry colname="c1">
                            <SimplePara>Mouse</SimplePara>
                          </entry>
                          <entry colname="c2">
                            <SimplePara>1:50</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry colname="c0">
                            <SimplePara>PDGFaR</SimplePara>
                          </entry>
                          <entry colname="c1">
                            <SimplePara>Mouse</SimplePara>
                          </entry>
                          <entry colname="c2">
                            <SimplePara>1:100</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry colname="c0">
                            <SimplePara>SSEA-4</SimplePara>
                          </entry>
                          <entry colname="c1">
                            <SimplePara>Mouse</SimplePara>
                          </entry>
                          <entry colname="c2">
                            <SimplePara>1:100</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry colname="c0">
                            <SimplePara>Tuj1</SimplePara>
                          </entry>
                          <entry colname="c1">
                            <SimplePara>Mouse</SimplePara>
                          </entry>
                          <entry colname="c2">
                            <SimplePara>1:500</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry colname="c0">
                            <SimplePara>GFAP</SimplePara>
                          </entry>
                          <entry colname="c1">
                            <SimplePara>Rabbit</SimplePara>
                          </entry>
                          <entry colname="c2">
                            <SimplePara>1:500</SimplePara>
                          </entry>
                        </row>
                      </tbody>
                    </tgroup>
                  </Table>
                </Para>
              </Section2>
            </Section1>
            <Section1 ID="Sec14_5">
              <Heading>Methods</Heading>
              <Section2 ID="Sec15_5">
                <Heading>OPC Generation from Neural Progenitor Cells</Heading>
                <Section3 ID="Sec16_5">
                  <Heading>Isolating and Plating Neural Progenitor Cells</Heading>
                  <Para>Day 1: CNS neural progenitor cells are isolated from four to five pups
<OrderedList>
                      <ListItem>
                        <ItemNumber>1.</ItemNumber>
                        <ItemContent>
                          <Para>Prepare oligodendrocyte culture media (see recipe below).</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>2.</ItemNumber>
                        <ItemContent>
                          <Para>Obtain and place 1-day old newborn pups on ice until comatose. Spray with EtOH and decapitate with scissors. While holding the head by the nose, carefully cut the skin and skull down the midline from back to front and peel away.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>3.</ItemNumber>
                        <ItemContent>
                          <Para>Lift the brain from the olfactory bulbs and place in a Petri dish filled with Hank’s balanced salt solution supplemented with penicillin and streptomycin on ice. Remove meninges and major blood vessels then cut away the frontal lobes, cerebellum, and brainstem. Cut away the cortices and isolate the striatum. Once isolated, place the tissue in another Petri dish containing cold culture media.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>4.</ItemNumber>
                        <ItemContent>
                          <Para>Repeat above steps with the rest of the pups until all of the striata are isolated and in the same Petri dish.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>5.</ItemNumber>
                        <ItemContent>
                          <Para>Aspirate media and mince tissue with sterile scalpel blade.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>6.</ItemNumber>
                        <ItemContent>
                          <Para>Add 10 ml of 0.05% trypsin–EDTA, incubate at 37°C for 5 min, gently triturate with fire-polished Pasteur pipette, and then return to incubator for another 5 min.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>7.</ItemNumber>
                        <ItemContent>
                          <Para>Add equal amounts 0.05% antitrypsin, spin down cells at 400 × <Emphasis Type="Italic">g</Emphasis> for 5 min, aspirate supernatant, and resuspend in 30 ml warm media supplemented with 20 ng/ml EGF. Transfer cellular suspension to uncoated low-adherent 6-well plates dispensing 5 ml per well. Place in incubator at 37°C and 5% CO<Subscript>2</Subscript> (<Emphasis Type="Italic">see</Emphasis>
                            <Emphasis Type="Bold">Note</Emphasis>
                            <InternalRef RefID="Sec38_5">1</InternalRef>).</Para>
                        </ItemContent>
                      </ListItem>
                    </OrderedList>
                  </Para>
                </Section3>
                <Section3 ID="Sec17_5">
                  <Heading>Growing and Feeding Spheres</Heading>
                  <Para>Day 2: Debris is removed at this stage and cells will agglomerate in clumps resembling neurospheres
<OrderedList>
                      <ListItem>
                        <ItemNumber>1.</ItemNumber>
                        <ItemContent>
                          <Para>Warm 30 ml of media.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>2.</ItemNumber>
                        <ItemContent>
                          <Para>Collect cells from 6-well plates and put into a 50-ml conical tube.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>3.</ItemNumber>
                        <ItemContent>
                          <Para>Spin down cells at 400 × <Emphasis Type="Italic">g</Emphasis> for 5 min. Aspirate supernatant and resuspend in fresh media supplemented with 20 ng/ml of EGF. Distribute 5 ml per well in the 6-well plate and return to incubator.</Para>
                        </ItemContent>
                      </ListItem>
                    </OrderedList>
                  </Para>
                  <Para>Day 3: Prepare plates for plating
<OrderedList>
                      <ListItem>
                        <ItemNumber>1.</ItemNumber>
                        <ItemContent>
                          <Para>Coat T75 (75 cm<Superscript>2</Superscript>) flask using 10 mg/ml poly-<Emphasis Type="SmallCaps">l</Emphasis>-lysine and 15 μg/ml laminin making sure that the surface is well coated. Leave at 4°C overnight. Before use, aspirate excess coating mixture, rinse one time with PBS, and replace with culture media.</Para>
                        </ItemContent>
                      </ListItem>
                    </OrderedList>
                  </Para>
                </Section3>
                <Section3 ID="Sec18_5">
                  <Heading>Plating Neurospheres</Heading>
                  <Para>Day 4: Neurospheres are plated, allowing for cell migration
<OrderedList>
                      <ListItem>
                        <ItemNumber>1.</ItemNumber>
                        <ItemContent>
                          <Para>Warm media.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>2.</ItemNumber>
                        <ItemContent>
                          <Para>Collect cells and place into a 50-ml conical tube. Spin cells at 400 × <Emphasis Type="Italic">g</Emphasis> for 5 min, aspirate supernatant and resuspend in fresh media without EGF. Add spheres to coated T75 and place in incubator. Cells will adhere overnight and begin to migrate.</Para>
                        </ItemContent>
                      </ListItem>
                    </OrderedList>
                  </Para>
                </Section3>
                <Section3 ID="Sec19_5">
                  <Heading>Day 5–6: Transplantation</Heading>
                  <Para>
                    <OrderedList>
                      <ListItem>
                        <ItemNumber>1.</ItemNumber>
                        <ItemContent>
                          <Para>Observe the cells at day 5 and if growing well (i.e. migrated and relatively confluent), then they are ready for use. If growing slower, change the media and keep for the next day.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>2.</ItemNumber>
                        <ItemContent>
                          <Para>For transplantation:<OrderedList>
                              <ListItem>
                                <ItemNumber>(a)</ItemNumber>
                                <ItemContent>
                                  <Para>Add a small amount of 0.05% trypsin–EDTA to flask and incubate at 37°C for 5 min. Take cells out of the incubator, add an equal amount of antitrypsin and triturate by aspirating up and down with a serological pipette to break apart large clusters.</Para>
                                </ItemContent>
                              </ListItem>
                              <ListItem>
                                <ItemNumber>(b)</ItemNumber>
                                <ItemContent>
                                  <Para>Spin at 400 × <Emphasis Type="Italic">g</Emphasis> for 5 min, aspirate supernatant and wash/resuspend cells with 10 ml of DMEM. Take a small sample of cells to perform cell count. Use 50 μl of cells with 50 μl of trypan blue. Perform cell count to determine total number of cells while washing cells two more times with media.</Para>
                                </ItemContent>
                              </ListItem>
                              <ListItem>
                                <ItemNumber>(c)</ItemNumber>
                                <ItemContent>
                                  <Para>On the last wash, resuspend cells in the amount of transplanted vehicle (DMEM or Hanks Balanced Salt Solution) needed to give you a final concentration of 12 × 10<Superscript>4</Superscript> cells/μl.</Para>
                                </ItemContent>
                              </ListItem>
                            </OrderedList>
                          </Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>3.</ItemNumber>
                        <ItemContent>
                          <Para>For in vitro characterization:<OrderedList>
                              <ListItem>
                                <ItemNumber>(a)</ItemNumber>
                                <ItemContent>
                                  <Para>Prepare polylysine–laminin coated slides using Lab tek chamber slides 24 h in advance. Prepare cells as described for transplantation. Resuspend cells in oligodendroycte culture media. Plate to a final concentration of 150,000 cells/cm<Superscript>2</Superscript>. To assess differentiation potential, cells can be grown on plated imaging slides for 7 days before fixation with 4% paraformaldehyde.</Para>
                                </ItemContent>
                              </ListItem>
                            </OrderedList>
                          </Para>
                        </ItemContent>
                      </ListItem>
                    </OrderedList>
                  </Para>
                </Section3>
              </Section2>
              <Section2 ID="Sec20_5">
                <Heading>OPC Generation from Human Embryonic Stem Cells</Heading>
                <Section3 ID="Sec21_5">
                  <Heading>Growing Stem Cells</Heading>
                  <Para>hESCs are grown and expanded on Matrigel-coated flasks until the appropriate numbers for differentiation are achieved.</Para>
                  <Para>Day before plating hESCs:
<OrderedList>
                      <ListItem>
                        <ItemNumber>1.</ItemNumber>
                        <ItemContent>
                          <Para>Coat T75 flasks by adding 1:30 diluted growth factor reduced Matrigel in KO-DMEM to flask. Swirl flask to ensure even spreading of solution and set in a 4°C refrigerator overnight. Before use, aspirate the Matrigel solution, replace with 20 ml of MEF-CM and place the flask for at least 1 h in the incubator for thermal and pH balance.</Para>
                        </ItemContent>
                      </ListItem>
                    </OrderedList>
                  </Para>
                  <Para>Day 1: Plating and initial growth
<OrderedList>
                      <ListItem>
                        <ItemNumber>2.</ItemNumber>
                        <ItemContent>
                          <Para>Warm 35 ml of MEF-CM in a 37°C water bath.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>3.</ItemNumber>
                        <ItemContent>
                          <Para>Quickly thaw a 1 ml vial of hESCs with approximately 1.5 × 10<Superscript>6</Superscript> cells and add 9 ml of MEF-CM. Spin cells down at 200 × <Emphasis Type="Italic">g</Emphasis> for 4 min and resuspended in 5 ml of MEF-CM media. Carefully break up the pellet. Do not break the cell clusters.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>4.</ItemNumber>
                        <ItemContent>
                          <Para>Add the resuspended cells to the flask and add 8 ng/ml of bFGF. Place the flask in an incubator at 37°C, 5% CO<Subscript>2</Subscript>.</Para>
                        </ItemContent>
                      </ListItem>
                    </OrderedList>
                  </Para>
                  <Para>Day 7–14: Growth and splitting/passaging.
<OrderedList>
                      <ListItem>
                        <ItemNumber>5.</ItemNumber>
                        <ItemContent>
                          <Para>Cells are fed with 20–30 ml of new MEF-CM and 8 ng/ml bFGF everyday. MEF-CM media is warmed and old media is aspirated and replaced with new MEF-CM + 8 ng/ml bFGF.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>6.</ItemNumber>
                        <ItemContent>
                          <Para>Once a week cells are split 1:4 or 1:6 when at a minimum of 70% confluence.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>7.</ItemNumber>
                        <ItemContent>
                          <Para>Coat plates with Matrigel as described above, 24 h in advance</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>8.</ItemNumber>
                        <ItemContent>
                          <Para>Prepare MEF-CM + 8 ng/ml bFGF</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>9.</ItemNumber>
                        <ItemContent>
                          <Para>Dissociate cells from the flasks by adding 10 ml of 1 mg/ml collagenase IV to the flask and leave in the incubator for 2–5 min (<Emphasis Type="Italic">see</Emphasis>
                            <Emphasis Type="Bold">Note</Emphasis>
                            <InternalRef RefID="Sec38_5">2</InternalRef>).</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>10.</ItemNumber>
                        <ItemContent>
                          <Para>Aspirate collagenase and wash cells with 10 ml D-PBS. Aspirate D-PBS and add 10 ml of new MEF-CM to the flask. Scrape the hESCs with a cell scraper.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>11.</ItemNumber>
                        <ItemContent>
                          <Para>Collect the cells and distribute according to the splitting ratio into newly coated flasks, add 8 ng/ml of bFGF to each.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>12.</ItemNumber>
                        <ItemContent>
                          <Para>Replace flasks in incubator.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>13.</ItemNumber>
                        <ItemContent>
                          <Para>Feed the cells daily by replacing with fresh media and 8 ng/ml of bFGF.</Para>
                        </ItemContent>
                      </ListItem>
                    </OrderedList>
                  </Para>
                </Section3>
                <Section3 ID="Sec22_5">
                  <Heading>Cellular Aggregates (Start of Differentiation)</Heading>
                  <Para>Differentiation is initiated by removing the cells from the adherent substrate and treating them with a new media composition (transition media) for the first 2 days and continuing with GRM for the rest of the protocol duration – to induce neural differentiation first, and later oligodendroglial differentiation.</Para>
                  <Para>Day 1:
<OrderedList>
                      <ListItem>
                        <ItemNumber>1.</ItemNumber>
                        <ItemContent>
                          <Para>Prepare 30 ml of transition media (TR) + 4 ng/ml bFGF for each T75 flask, prewarm and pH balance in a CO<Subscript>2</Subscript> incubator.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>2.</ItemNumber>
                        <ItemContent>
                          <Para>Treat hESCs with 10 ml per flask of 1 mg/ml collagenase IV for 2–5 min in incubator. Aspirate collagenase and wash cells with 10 ml of D-PBS.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>3.</ItemNumber>
                        <ItemContent>
                          <Para>Aspirate D-PBS and add 30 ml of new TR media to cells then scrape cells with cell scraper to dislodge. Collect cells from the flask into a 50 ml centrifuge tube and triturate cell aggregates to slightly break up large clumps (about 3–5 times).</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>4.</ItemNumber>
                        <ItemContent>
                          <Para>Distribute the cells to Costar low attachment 6-well plates (5 ml cell suspension in each well). Put in incubator at 37°C, 5% CO<Subscript>2</Subscript>.</Para>
                        </ItemContent>
                      </ListItem>
                    </OrderedList>
                  </Para>
                  <Para>Day 2:
<OrderedList>
                      <ListItem>
                        <ItemNumber>5.</ItemNumber>
                        <ItemContent>
                          <Para>Prepare 30ml of TR media + 4 ng/ml bFGF + 20 ng/ml EGF and 10 μM retinoic acid (RA) for each 6-well plate of cells (<Emphasis Type="Italic">see</Emphasis>
                            <Emphasis Type="Bold">Note</Emphasis>
                            <InternalRef RefID="Sec38_5">4</InternalRef>).</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>6.</ItemNumber>
                        <ItemContent>
                          <Para>Collect cells from each well in 6-well plates and combine into 50 ml centrifuge tube. Spin cells at 200 × g for 4 min.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>7.</ItemNumber>
                        <ItemContent>
                          <Para>Aspirate old media and add 30 ml of new TR media with supplements. Resuspend gently, and do not break the clusters.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>8.</ItemNumber>
                        <ItemContent>
                          <Para>Distribute 5 ml to each well in plate. Return cells to incubator.</Para>
                        </ItemContent>
                      </ListItem>
                    </OrderedList>
                  </Para>
                </Section3>
                <Section3 ID="Sec23_5">
                  <Heading>Yellow Sphere Formation/Neural Progenitor</Heading>
                  <Para>
                    <Emphasis Type="Italic">Day 3–10</Emphasis>: Small clusters of 20–50 cells can be seen floating in the media. At the end of this time period, yellow spheres can be clearly observed as the only growing elements in the culture. The use of RA everyday will cause caudalization of the progenitor population (<Emphasis Type="Italic">see</Emphasis>
                    <Emphasis Type="Bold">Note</Emphasis>
                    <InternalRef RefID="Sec38_5">3</InternalRef>).
<OrderedList>
                      <ListItem>
                        <ItemNumber>1.</ItemNumber>
                        <ItemContent>
                          <Para>Make GRM media and warm. Prepare 30–35 ml of GRM + 20 ng/ml of EGF + 10 μM of RA for each 6-well plate of cells. Use minimal light during feeding since RA is light sensitive. For the RA, use 1 μl for each ml of media from the 10 μM/ml stock solution. Keep the RA stock solution aliquoted according to the experiment size, in 100, 200, 300 μl cryovials, at −80°C. The thawed vial should be discarded after use.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>2.</ItemNumber>
                        <ItemContent>
                          <Para>Collect cells in 50-ml conical tube and centrifuge at 200 × <Emphasis Type="Italic">g</Emphasis> for 2 min. If supernatant contains debris, eliminate with a low force centrifugation.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>3.</ItemNumber>
                        <ItemContent>
                          <Para>Aspirate supernatant and add 30 ml of new GRM + EGF + RA media.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>4.</ItemNumber>
                        <ItemContent>
                          <Para>Do not dissociate clumps by aspiration.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>5.</ItemNumber>
                        <ItemContent>
                          <Para>Redistribute 5 ml in each well.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>6.</ItemNumber>
                        <ItemContent>
                          <Para>The procedure is done every day.</Para>
                          <Para>Day 11–15: Medium yellow clusters/spheres are the only cellular aggregates growing in the culture, and very likely to be macroscopically visible. The dark clusters have an irregular shape and a loose composition. Individual floating cells are discarded at every feeding procedure.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>7.</ItemNumber>
                        <ItemContent>
                          <Para>The cultures are fed every other day (Monday–Wednesday–Friday).</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>8.</ItemNumber>
                        <ItemContent>
                          <Para>Prepare 30 ml of GRM media + 20 ng/ml EGF for each plate of hESCs.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>9.</ItemNumber>
                        <ItemContent>
                          <Para>Collect cells and perform the same procedures as described for days 3–10 with a low centrifugation force (200 × <Emphasis Type="Italic">g</Emphasis> for 1–2 min)</Para>
                        </ItemContent>
                      </ListItem>
                    </OrderedList>
                  </Para>
                  <Para>Day 16–28: Large clusters</Para>
                  <Para>Yellow sphere growth continues as unhealthy cells are discarded.
<OrderedList>
                      <ListItem>
                        <ItemNumber>10.</ItemNumber>
                        <ItemContent>
                          <Para>Change media every M–W–F and always return cells to the incubator as soon as possible.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>11.</ItemNumber>
                        <ItemContent>
                          <Para>Prepare 30 ml of GRM media + 20 ng/ml of EGF for each plate of cells.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>12.</ItemNumber>
                        <ItemContent>
                          <Para>Cells are collected in 50 ml tubes and are left to settle on their own for 5–10 min.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>13.</ItemNumber>
                        <ItemContent>
                          <Para>Aspirate supernatant and add new media.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>14.</ItemNumber>
                        <ItemContent>
                          <Para>Agitate the tube and immediately collect 15 ml using a 25 ml pipette and distribute quickly in first three wells.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>15.</ItemNumber>
                        <ItemContent>
                          <Para>Agitate the tube again and collect the remaining 15 ml and distribute the rest in the other wells.</Para>
                        </ItemContent>
                      </ListItem>
                    </OrderedList>
                  </Para>
                </Section3>
                <Section3 ID="Sec24_5">
                  <Heading>Oligodendrocyte Progenitors</Heading>
                  <Para>Day 28: Purification is obtained by plating the yellow spheres on Matrigel-coated flasks. Plating will eliminate the dead or nonadherent cells and will promote an outward migration from the yellow spheres.
<OrderedList>
                      <ListItem>
                        <ItemNumber>1.</ItemNumber>
                        <ItemContent>
                          <Para>Prepare Matrigel-coated T75 flask with 1:30 Matrigel in KO-DMEM 24 h in advance.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>2.</ItemNumber>
                        <ItemContent>
                          <Para>Prepare 30 ml of GRM + 20 ng/ml EGF, place the media in the coated flask, and prebalance the temperature and pH for at least 1 h in the CO<Subscript>2</Subscript> incubator.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>3.</ItemNumber>
                        <ItemContent>
                          <Para>Collect cells from flask into a 50 ml centrifuge tube. Let the culture sit for 5 min.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>4.</ItemNumber>
                        <ItemContent>
                          <Para>Aspirate old media and add a small amount (5 ml) of prewarmed GRM + EGF.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>5.</ItemNumber>
                        <ItemContent>
                          <Para>Place the cells into the coated T75 flask with the balanced GRM.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>6.</ItemNumber>
                        <ItemContent>
                          <Para>Return to incubator at 37°C, 5% CO<Subscript>2</Subscript>.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>7.</ItemNumber>
                        <ItemContent>
                          <Para>The next day, gently shake the plated flask to dislodge nonadherent debris.</Para>
                        </ItemContent>
                      </ListItem>
                    </OrderedList>
                  </Para>
                  <Para>Day 29–34: Oligodendrocyte progenitors grow and migrate out from the yellow spheres.
<OrderedList>
                      <ListItem>
                        <ItemNumber>8.</ItemNumber>
                        <ItemContent>
                          <Para>Change media every M-W-F.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>9.</ItemNumber>
                        <ItemContent>
                          <Para>Prepare 30 ml of GRM + 20 ng/ml EGF for each Matrigel-coated flask.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>10.</ItemNumber>
                        <ItemContent>
                          <Para>Aspirate old media.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>11.</ItemNumber>
                        <ItemContent>
                          <Para>Add 30 ml of new GRM + EGF to flask. Return to incubator.</Para>
                        </ItemContent>
                      </ListItem>
                    </OrderedList>
                  </Para>
                  <Para>Day 35–42: Purification, replating and imaging</Para>
                  <Para>The cultures will go through a purification process where contaminant cells (astrocytes, fibroblasts) are removed and the remaining oligodendrocyte progenitors are replated. At the same time cells are plated on imaging slides, to be used later for immunocytochemistry, while the rest of the culture is prepared for in vivo use. A 1:2 splitting ratio is used for this step.
<OrderedList>
                      <ListItem>
                        <ItemNumber>12.</ItemNumber>
                        <ItemContent>
                          <Para>Prepare the required Matrigel-coated T75 flasks with 1:30 Matrigel in KO-DMEM 24 h in advance.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>13.</ItemNumber>
                        <ItemContent>
                          <Para>Add 25 ml of GRM + EGF to each flask; prewarm and balance the pH of the media in the CO<Subscript>2</Subscript> incubator 1 h before use.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>14.</ItemNumber>
                        <ItemContent>
                          <Para>Prepare Matrigel 1:30 or laminin (10 μg/ml/cm<Superscript>2</Superscript>) coated imaging slides one day in advance. Replace the coating solution with media, omitting the growth factor, and place the slides in the CO<Subscript>2</Subscript> incubator for temperature and pH balance 1 h before use.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>15.</ItemNumber>
                        <ItemContent>
                          <Para>Aspirate media from each cell containing flask. Wash with 10 ml D-PBS. Aspirate again.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>16.</ItemNumber>
                        <ItemContent>
                          <Para>Add 7 ml of warm 0.05% trypsin–EDTA to flask. Incubate 5–10 min at 37°C.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>17.</ItemNumber>
                        <ItemContent>
                          <Para>Add 7 ml of antitrypsin solution to the flask. Collect the cells into a 15 ml centrifuge tube and mix.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>18.</ItemNumber>
                        <ItemContent>
                          <Para>Take a small sample of cells to perform a cell count. Take 50 μl of cells and mix with 50 μl of trypan blue. Perform cell count for total number of cells recovered.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>19.</ItemNumber>
                        <ItemContent>
                          <Para>Spin the cells at 250 × <Emphasis Type="Italic">g</Emphasis> for 5 min.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>20.</ItemNumber>
                        <ItemContent>
                          <Para>Aspirate media and resuspend in 50 ml of GRM media. Transfer cells to two T75 or one T150 bare plastic flasks and incubate for 1 h at 37°C. This step allows all of the astrocytes to attach to the plastic bottom, while the less adherent oligodendrocytes will float in the media.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>21.</ItemNumber>
                        <ItemContent>
                          <Para>Collect media with a gentle shake from the plastic flasks and transfer to centrifuge tubes.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>22.</ItemNumber>
                        <ItemContent>
                          <Para>Take a sample from the purified cells for the laminin imaging slides. Dilute cells to 50,000 cells/ml/cm<Superscript>2</Superscript>. EGF is omitted from the media. After 2 days the cells are ready to be fixed and stained.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>23.</ItemNumber>
                        <ItemContent>
                          <Para>The rest of the purified cells are split into two Matrigel-coated T75 flasks prepared earlier containing GRM + 20 ng/ml EGF. After 7 days of growth, they are ready to be used (<Emphasis Type="Italic">see</Emphasis>
                            <Emphasis Type="Bold">Note</Emphasis>
                            <InternalRef RefID="Sec38_5">5</InternalRef>).</Para>
                        </ItemContent>
                      </ListItem>
                    </OrderedList>
                  </Para>
                </Section3>
              </Section2>
              <Section2 ID="Sec25_5">
                <Heading>Cell Identification</Heading>
                <Section3 ID="Sec26_5">
                  <Heading>Morphology
Growing Stem Cells
(Undifferentiated)</Heading>
                  <Para>Every stage during hESC differentiation has distinct cellular or cellular aggregate morphology detailed below. If growing OPCs from striatal preparations, cellular descriptions start at sphere formation and their morphology is very similar to the hESC lines.</Para>
                  <Section4 ID="Sec27_5">
                    <Heading>Growing Stem Cells (Undifferentiated)</Heading>
                    <Para>Healthy undifferentiated stem cells grow in circular clusters with a smooth looking surface. Some of the clusters will have some multilayered areas and some spontaneously differentiated areas. Individual cells will be in-between clusters as they spontaneously differentiate and migrate. Confluence is usually attained within 5–7 days.</Para>
                  </Section4>
                  <Section4 ID="Sec28_5">
                    <Heading>Cellular Aggregates</Heading>
                    <Para>Aggregate clusters appear after dissociation of hESCs cultures. The large stem cell clusters first break apart and then round up. They will not be perfectly spherical and they will have various sizes. Isolated floating cells are usually nonviable and are discarded at feeding with low force centrifugation. Some published research refers to these aggregates as “embryoid bodies”. We have not demonstrated the presence of the three embryonic layers, so refer to them as “cellular aggregates” instead.</Para>
                  </Section4>
                  <Section4 ID="Sec29_5">
                    <Heading>Yellow Spheres/Neural Progenitors</Heading>
                    <Para>Spheres grow from the aggregate clusters, take a perfect spherical morphology, and are bright yellow. Small and large yellow spheres will be surrounded by cellular debris. The spheres should be homogenous and no dark, necrotic centers should be observed. This stage is crucial for selecting healthy spheres and patience is necessary for proper selection. Some spheres will adhere to each other.</Para>
                    <Para>During this stage, more and more yellow spheres are produced and there are fewer contaminants seen with time.</Para>
                  </Section4>
                  <Section4 ID="Sec30_5">
                    <Heading>Oligodendrocyte Progenitors</Heading>
                    <Para>Plating of neural progenitors allows selection of viable cells, self-dissociation of the spheres, and further differentiation of neural progenitors into OPCs. During this stage, the migrated cells can look flat reassembling an epithelial morphology or they can have a bipolar morphology with short thick branches. Most importantly, they are positive for oligodendrocyte markers such as Olig1 and NG2. Some plated yellow spheres will extend long processes first, followed by migration of the OPCs along the radial branches over the next few days.</Para>
                  </Section4>
                  <Section4 ID="Sec31_5">
                    <Heading>Oligodendrocytes</Heading>
                    <Para>After plating at low density in a growth factor free medium, some of the cells will develop the fully mature shape of oligodendrocytes with branches and sheets, staining positive for all oligodendroglial markers.</Para>
                  </Section4>
                </Section3>
                <Section3 ID="Sec32_5">
                  <Heading>Markers</Heading>
                  <Para>Note: These markers are generally good for both neural and embryonic derived populations.</Para>
                  <Section4 ID="Sec33_5">
                    <Heading>Growing Stem Cells (Undifferentiated)</Heading>
                    <Para>Good markers for this stage are:
<UnorderedList Mark="Dash">
                        <ItemContent>
                          <Para>SSEA-4: a surface marker of pluripotent cells</Para>
                        </ItemContent>
                        <ItemContent>
                          <Para>Oct4: nuclear marker, transcription factor</Para>
                        </ItemContent>
                      </UnorderedList>
                    </Para>
                  </Section4>
                  <Section4 ID="Sec34_5">
                    <Heading>Cellular Aggregates</Heading>
                    <Para>This is a transition stage and when plated on adherent substrate many cells will stain positive for embryonic markers (SSEA, OCT4) and while others will start to stain for neural progenitors such as nestin and A2B5 after approximately 3 days. They reassemble neurogenic cores surrounded by nonlabeled cells.</Para>
                  </Section4>
                  <Section4 ID="Sec35_5">
                    <Heading>Spheres/Neural Progenitors</Heading>
                    <Para>Early yellow spheres (up to day 21) plated on adherent substrate will stain positive for:
<UnorderedList Mark="Dash">
                        <ItemContent>
                          <Para>Pax6: A transcription factor for neural commitment</Para>
                        </ItemContent>
                        <ItemContent>
                          <Para>A2B5: marker for early neural progenitors</Para>
                        </ItemContent>
                        <ItemContent>
                          <Para>Nestin: marker for neural commitment</Para>
                        </ItemContent>
                        <ItemContent>
                          <Para>Olig1 or Olig2: a transcription factor involved in oligodendroglial development</Para>
                        </ItemContent>
                      </UnorderedList>
                    </Para>
                  </Section4>
                  <Section4 ID="Sec36_5">
                    <Heading>
Oligodendrocyte
Progenitors
</Heading>
                    <Para>Typical markers for OPCs are:
<UnorderedList Mark="Dash">
                        <ItemContent>
                          <Para>Olig1 or Olig2: transcription factor specific for pMN domain</Para>
                        </ItemContent>
                        <ItemContent>
                          <Para>NG2: Chondrotin sulfate proteoglycan expressed by OPCs</Para>
                        </ItemContent>
                        <ItemContent>
                          <Para>PDGFαR: specific for young oligodendrocytes or early OPCs</Para>
                        </ItemContent>
                        <ItemContent>
                          <Para>SOX10: a shuttle protein (nuclear and cytoplasmic) involved in oligodendrocyte differentiation also positive in young and mature oligodendrocytes</Para>
                        </ItemContent>
                      </UnorderedList>
                    </Para>
                    <Para>Contaminants:
<UnorderedList Mark="Dash">
                        <ItemContent>
                          <Para>GFAP: marker for astrocytes which contaminate the OPC cultures (usually less than 5%).</Para>
                        </ItemContent>
                        <ItemContent>
                          <Para>Neurofilaments (bTubulin, MAP2, Tuj1 etc): positive for neurons (sometimes up to 10%)</Para>
                        </ItemContent>
                        <ItemContent>
                          <Para>SMA (Smooth Muscle Actin): occasionally single cells are found in the culture (less than 0.1%)</Para>
                        </ItemContent>
                      </UnorderedList>
                    </Para>
                    <Para>Each of these antibodies requires slightly different protocols for immunostaining; we have provided a table above noting some of the differences. The general protocol for immunocytochemistry is provided below.</Para>
                  </Section4>
                  <Section4 ID="Sec37_5">
                    <Heading>Immunostaining Procedure</Heading>
                    <Para>
                      <OrderedList>
                        <ListItem>
                          <ItemNumber>1.</ItemNumber>
                          <ItemContent>
                            <Para>Fix cultures for 10 min at room temperature (RT) in 4% paraformaldehyde</Para>
                          </ItemContent>
                        </ListItem>
                        <ListItem>
                          <ItemNumber>2.</ItemNumber>
                          <ItemContent>
                            <Para>Wash 3× saline phosphate buffer (PBS) for 5 min each</Para>
                          </ItemContent>
                        </ListItem>
                        <ListItem>
                          <ItemNumber>3.</ItemNumber>
                          <ItemContent>
                            <Para>Wash in 1% BSA + 0.1% trition-X in PBS for 15 min at RT</Para>
                          </ItemContent>
                        </ListItem>
                        <ListItem>
                          <ItemNumber>4.</ItemNumber>
                          <ItemContent>
                            <Para>Wash 3× PBS for 5 min each</Para>
                          </ItemContent>
                        </ListItem>
                        <ListItem>
                          <ItemNumber>5.</ItemNumber>
                          <ItemContent>
                            <Para>Dilute primary antibodies in 1% BSA in PBS at dilutions noted in the table above. Leave antibody incubation overnight in 4°C</Para>
                          </ItemContent>
                        </ListItem>
                        <ListItem>
                          <ItemNumber>6.</ItemNumber>
                          <ItemContent>
                            <Para>Wash 3× PBS for 5 min each</Para>
                          </ItemContent>
                        </ListItem>
                        <ListItem>
                          <ItemNumber>7.</ItemNumber>
                          <ItemContent>
                            <Para>Block with 10% goat serum in PBS for 30 min at RT</Para>
                          </ItemContent>
                        </ListItem>
                        <ListItem>
                          <ItemNumber>8.</ItemNumber>
                          <ItemContent>
                            <Para>Wash 3× PBS for 5 min each</Para>
                          </ItemContent>
                        </ListItem>
                        <ListItem>
                          <ItemNumber>9.</ItemNumber>
                          <ItemContent>
                            <Para>Add AlexaFluor secondary antibody according to the primary host species (antimouse or antirabbit) 1:200 in PBS for 1 h RT</Para>
                          </ItemContent>
                        </ListItem>
                        <ListItem>
                          <ItemNumber>10.</ItemNumber>
                          <ItemContent>
                            <Para>Wash 3× PBS for 5 min each</Para>
                          </ItemContent>
                        </ListItem>
                        <ListItem>
                          <ItemNumber>11.</ItemNumber>
                          <ItemContent>
                            <Para>Counter stain with Hoechst (1:1,000) for 5 min RT</Para>
                          </ItemContent>
                        </ListItem>
                        <ListItem>
                          <ItemNumber>12.</ItemNumber>
                          <ItemContent>
                            <Para>Wash 3× PBS for 5 min each and one time with dH<Subscript>2</Subscript>O</Para>
                          </ItemContent>
                        </ListItem>
                        <ListItem>
                          <ItemNumber>13.</ItemNumber>
                          <ItemContent>
                            <Para>Coverslip with an aqueous mounting media</Para>
                          </ItemContent>
                        </ListItem>
                      </OrderedList>
                    </Para>
                    <Para>With Alexa Fluor conjugated secondary antibodies, we found persistent fluorescence after 1 year while the slides were kept at room temperature.</Para>
                  </Section4>
                </Section3>
              </Section2>
            </Section1>
            <Section1 ID="Sec38_5">
              <Heading>Notes</Heading>
              <Para>Variations from the given protocol can be done with certain limitations. We found that the timing and the growth factor sequence is critical. The cultures are tolerant to changes in the concentration of supplements; however, the outcome will be reflected in the oligodendrocyte vs. contaminant cell yield.
<OrderedList>
                  <ListItem>
                    <ItemNumber>1.</ItemNumber>
                    <ItemContent>
                      <Para>
                        <Emphasis Type="Italic">Contamination</Emphasis>. Due to the long protocol (42 days), most of the problems that arise in stem cell differentiation are a result of improper sterile technique resulting in contamination. It is best to always be as sterile as possible and be on the lookout for unusual growth. If contamination is caught early, the cells may still be salvaged. Repeated washing with sterile HBSS at feeding and addition of antibiotic for a week can restore the cultures. If contamination persists, the cultures must be destroyed and the incubator decontaminated. In such an event, we prefer to decontaminate the entire cell culture room. Some preventative procedures to follow are: (a) Always work in a certified biosafety hood and calibrate the incubators at least once a year. (b) Spray anything that goes into the hood with generous amounts of 70% ethanol or alternative disinfectant (bleach, or commercially available products). (c) Spray down the hood itself before and after each use. (d) Ethanol treat your gloves often. (e) Use barrier tips for all pipetting. (f) Do not leave wrappers from tips, used tubes, or extra debris in the hood. Always remove things directly after use. (g) Never leave the incubator door open. (h) Rinse aspiration tube after each use with 30% bleach. (i) Keep all flask caps and 6-well plate lids clean from media or liquid. Replace wet caps and lids with new, clean ones. (j) Keep all areas separate from other tissue/cellular use. If possible use the room and hood only for stem cells. This will decrease contamination from other cell lines. (k) Aliquot reagents or supplements into one dose vials. (l) Do not work with the cells when you are sick (flu, cold) and always wear a mask during the epidemic season. (m) As the major source of contamination, water baths should be completely eliminated from the critical cell culture rooms. The media has to be left in the 37°C for 1 h for pH and temperature balance. (n) Check the water level in the incubator to prevent evaporation of media resulting in hyperosmolarity and sudden cell death.</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>2.</ItemNumber>
                    <ItemContent>
                      <Para>
                        <Emphasis Type="Italic">Extensive cellular death</Emphasis> at the stem cell culture dissociation step: This is caused by the overgrowth of the stem cell culture and cannot be recovered. Consider adding more media; make 2 × 6 well plates from one stem cell flasks.</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>3.</ItemNumber>
                    <ItemContent>
                      <Para>
                        <Emphasis Type="Italic">Yellow spheres are not forming</Emphasis>. Low density or nondifferentiating stem cells. The quality of the stem cell cultures is crucial for good differentiation and can be appreciated by the spontaneous differentiation tendency. A good starting stem cell culture should have abundant stromal cells, and large stem cell clusters sharply delimited with a smooth edge. In our experience, cultures with low or absent spontaneous differentiation (reflected in the abundance of stromal cells) generated very low yields of OPCs. In these cultures, hollow cystic cell agglomerates are common, and fail to evolve. Cultures with too much spontaneous differentiation (multilayered clusters) generated more neuronal contaminants.</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>4.</ItemNumber>
                    <ItemContent>
                      <Para>
                        <Emphasis Type="Italic">The retinoic acid quality</Emphasis> can be incriminated if failure of differentiation is observed. The old stock should be replaced after 3 months. A good, active RA is bright yellow, but is degraded very quickly by fluorescent light and the yellow intensity is visibly faded.</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>5.</ItemNumber>
                    <ItemContent>
                      <Para>
                        <Emphasis Type="Italic">Failing terminal differentiation</Emphasis>. The plating density for terminal differentiation in the absence of growth factors is critical. If the density is high, the cells will proliferate. If density is too low, the cells do not survive. During characterization of plated imaging slides, we often see a mixture of young and semimature oligodendrocytes.</Para>
                    </ItemContent>
                  </ListItem>
                </OrderedList>
              </Para>
            </Section1>
          </Body>
          <BodyRef FileRef="BodyRef/PDF/978-1-60327-931-4_Chapter_5.pdf" OutputMedium="Online" PDFType="Typeset" TargetType="OnlinePDF"/>
          <ChapterBackmatter>
            <Bibliography ID="Bib1_5">
              <Heading>References</Heading>
              <Citation ID="CR1_5">
                <CitationNumber>1.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>J.</Initials>
                    <FamilyName>Cervos-Navarro</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J. V.</Initials>
                    <FamilyName>Lafuente</FamilyName>
                  </BibAuthorName>
                  <Year>1991</Year>
                  <ArticleTitle Language="En">“Traumatic brain injuries: structural changes.</ArticleTitle>
                  <JournalTitle>J Neurol Sci</JournalTitle>
                  <VolumeID>103</VolumeID>
                  <IssueID>Suppl</IssueID>
                  <FirstPage>S3</FirstPage>
                  <LastPage>14</LastPage>
                  <Occurrence Type="PID">
                    <Handle>1940963</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/0022-510X(91)90002-O</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Cervos-Navarro, J. and J. V. Lafuente (1991). “Traumatic brain injuries: structural changes.” J Neurol Sci 103(Suppl): S3–14.</BibUnstructured>
              </Citation>
              <Citation ID="CR2_5">
                <CitationNumber>2.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>H.</Initials>
                    <FamilyName>Lassmann</FamilyName>
                  </BibAuthorName>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">“Classification of demyelinating diseases at the interface between etiology and pathogenesis.</ArticleTitle>
                  <JournalTitle>Curr Opin Neurol</JournalTitle>
                  <VolumeID>14</VolumeID>
                  <IssueID>3</IssueID>
                  <FirstPage>253</FirstPage>
                  <LastPage>8</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11371746</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1097/00019052-200106000-00001</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DC%2BD3M3nslOgsg%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Lassmann, H. (2001). “Classification of demyelinating diseases at the interface between etiology and pathogenesis.” Curr Opin Neurol 14(3): 253–8.</BibUnstructured>
              </Citation>
              <Citation ID="CR3_5">
                <CitationNumber>3.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>V.</Initials>
                    <FamilyName>Engelbrecht</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A.</Initials>
                    <FamilyName>Scherer</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">“Diffusion-weighted MR imaging in the brain in children: findings in the normal brain and in the brain with white matter diseases.</ArticleTitle>
                  <JournalTitle>Radiology</JournalTitle>
                  <VolumeID>222</VolumeID>
                  <IssueID>2</IssueID>
                  <FirstPage>410</FirstPage>
                  <LastPage>8</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11818607</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1148/radiol.2222010492</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Engelbrecht, V., A. Scherer, et al (2002). “Diffusion-weighted MR imaging in the brain in children: findings in the normal brain and in the brain with white matter diseases.” Radiology 222(2): 410–8.</BibUnstructured>
              </Citation>
              <Citation ID="CR4_5">
                <CitationNumber>4.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>G.</Initials>
                    <FamilyName>Bartzokis</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P. H.</Initials>
                    <FamilyName>Lu</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">“Quantifying age-related myelin breakdown with MRI: novel therapeutic targets for preventing cognitive decline and Alzheimer’s disease.</ArticleTitle>
                  <JournalTitle>J Alzheimers Dis</JournalTitle>
                  <VolumeID>6</VolumeID>
                  <IssueID>6 Suppl</IssueID>
                  <FirstPage>S53</FirstPage>
                  <LastPage>9</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15665415</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2MXisVOksLw%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Bartzokis, G., P. H. Lu, et al (2004). “Quantifying age-related myelin breakdown with MRI: novel therapeutic targets for preventing cognitive decline and Alzheimer’s disease.” J Alzheimers Dis 6(6 Suppl): S53–9.</BibUnstructured>
              </Citation>
              <Citation ID="CR5_5">
                <CitationNumber>5.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>E.</Initials>
                    <FamilyName>Capello</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G. L.</Initials>
                    <FamilyName>Mancardi</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">“Marburg type and Balo’s concentric sclerosis: rare and acute variants of multiple sclerosis.</ArticleTitle>
                  <JournalTitle>Neurol Sci</JournalTitle>
                  <VolumeID>25</VolumeID>
                  <IssueID>Suppl 4</IssueID>
                  <FirstPage>S361</FirstPage>
                  <LastPage>3</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15727234</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1007/s10072-004-0341-1</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Capello, E. and G. L. Mancardi (2004). “Marburg type and Balo’s concentric sclerosis: rare and acute variants of multiple sclerosis.” Neurol Sci 25(Suppl 4): S361–3.</BibUnstructured>
              </Citation>
              <Citation ID="CR6_5">
                <CitationNumber>6.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>K. H.</Initials>
                    <FamilyName>Levin</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">“Variants and mimics of Guillain Barre Syndrome.</ArticleTitle>
                  <JournalTitle>Neurologist</JournalTitle>
                  <VolumeID>10</VolumeID>
                  <IssueID>2</IssueID>
                  <FirstPage>61</FirstPage>
                  <LastPage>74</LastPage>
                  <Occurrence Type="PID">
                    <Handle>14998436</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1097/01.nrl.0000117821.35196.0b</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Levin, K. H. (2004). “Variants and mimics of Guillain Barre Syndrome.” Neurologist 10(2): 61–74.</BibUnstructured>
              </Citation>
              <Citation ID="CR7_5">
                <CitationNumber>7.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>H. S.</Initials>
                    <FamilyName>Keirstead</FamilyName>
                  </BibAuthorName>
                  <Year>2005</Year>
                  <ArticleTitle Language="En">“Stem cells for the treatment of myelin loss.</ArticleTitle>
                  <JournalTitle>Trends Neurosci</JournalTitle>
                  <VolumeID>28</VolumeID>
                  <IssueID>12</IssueID>
                  <FirstPage>677</FirstPage>
                  <LastPage>83</LastPage>
                  <Occurrence Type="PID">
                    <Handle>16213602</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/j.tins.2005.09.008</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2MXht1Ggtb%2FL</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Keirstead, H. S. (2005). “Stem cells for the treatment of myelin loss.” Trends Neurosci 28(12): 677–83.</BibUnstructured>
              </Citation>
              <Citation ID="CR8_5">
                <CitationNumber>8.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>R. A.</Initials>
                    <FamilyName>Lewis</FamilyName>
                  </BibAuthorName>
                  <Year>2005</Year>
                  <ArticleTitle Language="En">“Chronic inflammatory demyelinating polyneuropathy and other immune-mediated demyelinating neuropathies.</ArticleTitle>
                  <JournalTitle>Semin Neurol</JournalTitle>
                  <VolumeID>25</VolumeID>
                  <IssueID>2</IssueID>
                  <FirstPage>217</FirstPage>
                  <LastPage>28</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15937737</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1055/s-2005-871330</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Lewis, R. A. (2005). “Chronic inflammatory demyelinating polyneuropathy and other immune-mediated demyelinating neuropathies.” Semin Neurol 25(2): 217–28.</BibUnstructured>
              </Citation>
              <Citation ID="CR9_5">
                <CitationNumber>9.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>M. O.</Initials>
                    <FamilyName>Totoiu</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H. S.</Initials>
                    <FamilyName>Keirstead</FamilyName>
                  </BibAuthorName>
                  <Year>2005</Year>
                  <ArticleTitle Language="En">“Spinal cord injury is accompanied by chronic progressive demyelination.</ArticleTitle>
                  <JournalTitle>J Comp Neurol</JournalTitle>
                  <VolumeID>486</VolumeID>
                  <IssueID>4</IssueID>
                  <FirstPage>373</FirstPage>
                  <LastPage>83</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15846782</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1002/cne.20517</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Totoiu, M. O. and H. S. Keirstead (2005). “Spinal cord injury is accompanied by chronic progressive demyelination.” J Comp Neurol 486(4): 373–83.</BibUnstructured>
              </Citation>
              <Citation ID="CR10_5">
                <CitationNumber>10.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>N.</Initials>
                    <FamilyName>De Stefano</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P. M.</Initials>
                    <FamilyName>Matthews</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>1998</Year>
                  <ArticleTitle Language="En">“Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study.</ArticleTitle>
                  <JournalTitle>Brain</JournalTitle>
                  <VolumeID>121</VolumeID>
                  <IssueID>Pt 8</IssueID>
                  <FirstPage>1469</FirstPage>
                  <LastPage>77</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9712009</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1093/brain/121.8.1469</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>De Stefano, N., P. M. Matthews, et al (1998). “Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study.” Brain 121(Pt 8): 1469–77.</BibUnstructured>
              </Citation>
              <Citation ID="CR11_5">
                <CitationNumber>11.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>C.</Initials>
                    <FamilyName>Bjartmar</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>X.</Initials>
                    <FamilyName>Yin</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>1999</Year>
                  <ArticleTitle Language="En">“Axonal pathology in myelin disorders.</ArticleTitle>
                  <JournalTitle>J Neurocytol</JournalTitle>
                  <VolumeID>28</VolumeID>
                  <IssueID>4–5</IssueID>
                  <FirstPage>383</FirstPage>
                  <LastPage>95</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10739578</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1023/A:1007010205037</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3cXktF2gur0%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Bjartmar, C., X. Yin, et al (1999). “Axonal pathology in myelin disorders.” J Neurocytol 28(4–5): 383–95.</BibUnstructured>
              </Citation>
              <Citation ID="CR12_5">
                <CitationNumber>12.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>B. D.</Initials>
                    <FamilyName>Trapp</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L.</Initials>
                    <FamilyName>Bo</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>1999</Year>
                  <ArticleTitle Language="En">“Pathogenesis of tissue injury in MS lesions.</ArticleTitle>
                  <JournalTitle>J Neuroimmunol</JournalTitle>
                  <VolumeID>98</VolumeID>
                  <IssueID>1</IssueID>
                  <FirstPage>49</FirstPage>
                  <LastPage>56</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10426362</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0165-5728(99)00081-8</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1MXktVGru7c%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Trapp, B. D., L. Bo, et al (1999). “Pathogenesis of tissue injury in MS lesions.” J Neuroimmunol 98(1): 49–56.</BibUnstructured>
              </Citation>
              <Citation ID="CR13_5">
                <CitationNumber>13.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>D.</Initials>
                    <FamilyName>Giulian</FamilyName>
                  </BibAuthorName>
                  <Year>1993</Year>
                  <ArticleTitle Language="En">“Reactive glia as rivals in regulating neuronal survival.</ArticleTitle>
                  <JournalTitle>Glia</JournalTitle>
                  <VolumeID>7</VolumeID>
                  <IssueID>1</IssueID>
                  <FirstPage>102</FirstPage>
                  <LastPage>10</LastPage>
                  <Occurrence Type="PID">
                    <Handle>8423057</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1002/glia.440070116</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaK3s7jvVOgtQ%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Giulian, D. (1993). “Reactive glia as rivals in regulating neuronal survival.” Glia 7(1): 102–10.</BibUnstructured>
              </Citation>
              <Citation ID="CR14_5">
                <CitationNumber>14.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>D.</Initials>
                    <FamilyName>Giulian</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M.</Initials>
                    <FamilyName>Corpuz</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>1993</Year>
                  <ArticleTitle Language="En">“Reactive mononuclear phagocytes release neurotoxins after ischemic and traumatic injury to the central nervous system.</ArticleTitle>
                  <JournalTitle>J Neurosci Res</JournalTitle>
                  <VolumeID>36</VolumeID>
                  <IssueID>6</IssueID>
                  <FirstPage>681</FirstPage>
                  <LastPage>93</LastPage>
                  <Occurrence Type="PID">
                    <Handle>8145296</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1002/jnr.490360609</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2cXltFOitA%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Giulian, D., M. Corpuz, et al (1993). “Reactive mononuclear phagocytes release neurotoxins after ischemic and traumatic injury to the central nervous system.” J Neurosci Res 36(6): 681–93.</BibUnstructured>
              </Citation>
              <Citation ID="CR15_5">
                <CitationNumber>15.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>J.</Initials>
                    <FamilyName>Silver</FamilyName>
                  </BibAuthorName>
                  <Year>1994</Year>
                  <ArticleTitle Language="En">“Inhibitory molecules in development and regeneration.</ArticleTitle>
                  <JournalTitle>J Neurol</JournalTitle>
                  <VolumeID>242</VolumeID>
                  <IssueID>1 Suppl 1</IssueID>
                  <FirstPage>S22</FirstPage>
                  <LastPage>4</LastPage>
                  <Occurrence Type="PID">
                    <Handle>7535345</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1007/BF00939236</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaK2M3htlOmsw%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Silver, J. (1994). “Inhibitory molecules in development and regeneration.” J Neurol 242(1 Suppl 1): S22–4.</BibUnstructured>
              </Citation>
              <Citation ID="CR16_5">
                <CitationNumber>16.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>J.</Initials>
                    <FamilyName>Qiu</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D.</Initials>
                    <FamilyName>Cai</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">“Glial inhibition of nerve regeneration in the mature mammalian CNS.</ArticleTitle>
                  <JournalTitle>Glia</JournalTitle>
                  <VolumeID>29</VolumeID>
                  <IssueID>2</IssueID>
                  <FirstPage>166</FirstPage>
                  <LastPage>74</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10625335</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1002/(SICI)1098-1136(20000115)29:2&lt;166::AID-GLIA10&gt;3.0.CO;2-G</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DC%2BD3c%2FptVyisA%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Qiu, J., D. Cai, et al (2000). “Glial inhibition of nerve regeneration in the mature mammalian CNS.” Glia 29(2): 166–74.</BibUnstructured>
              </Citation>
              <Citation ID="CR17_5">
                <CitationNumber>17.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>A. E.</Initials>
                    <FamilyName>Fournier</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S. M.</Initials>
                    <FamilyName>Strittmatter</FamilyName>
                  </BibAuthorName>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">“Repulsive factors and axon regeneration in the CNS.</ArticleTitle>
                  <JournalTitle>Curr Opin Neurobiol</JournalTitle>
                  <VolumeID>11</VolumeID>
                  <IssueID>1</IssueID>
                  <FirstPage>89</FirstPage>
                  <LastPage>94</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11179877</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0959-4388(00)00178-1</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXhslGltb8%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Fournier, A. E. and S. M. Strittmatter (2001). “Repulsive factors and axon regeneration in the CNS.” Curr Opin Neurobiol 11(1): 89–94.</BibUnstructured>
              </Citation>
              <Citation ID="CR18_5">
                <CitationNumber>18.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>P.</Initials>
                    <FamilyName>Charles</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R.</Initials>
                    <FamilyName>Reynolds</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">“Re-expression of PSA-NCAM by demyelinated axons: an inhibitor of remyelination in multiple sclerosis?</ArticleTitle>
                  <JournalTitle>Brain</JournalTitle>
                  <VolumeID>125</VolumeID>
                  <IssueID>Pt 9</IssueID>
                  <FirstPage>1972</FirstPage>
                  <LastPage>9</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12183343</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1093/brain/awf216</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Charles, P., R. Reynolds, et al (2002). “Re-expression of PSA-NCAM by demyelinated axons: an inhibitor of remyelination in multiple sclerosis?” Brain 125(Pt 9): 1972–9.</BibUnstructured>
              </Citation>
              <Citation ID="CR19_5">
                <CitationNumber>19.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>F. F.</Initials>
                    <FamilyName>Santos-Benito</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A.</Initials>
                    <FamilyName>Ramon-Cueto</FamilyName>
                  </BibAuthorName>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">“Olfactory ensheathing glia transplantation: a therapy to promote repair in the mammalian central nervous system.</ArticleTitle>
                  <JournalTitle>Anat Rec B New Anat</JournalTitle>
                  <VolumeID>271</VolumeID>
                  <IssueID>1</IssueID>
                  <FirstPage>77</FirstPage>
                  <LastPage>85</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12619089</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1002/ar.b.10015</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Santos-Benito, F. F. and A. Ramon-Cueto (2003). “Olfactory ensheathing glia transplantation: a therapy to promote repair in the mammalian central nervous system.” Anat Rec B New Anat 271(1): 77–85.</BibUnstructured>
              </Citation>
              <Citation ID="CR20_5">
                <CitationNumber>20.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>K. J.</Initials>
                    <FamilyName>Smith</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>W. I.</Initials>
                    <FamilyName>McDonald</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>1979</Year>
                  <ArticleTitle Language="En">“Restoration of secure conduction by central demyelination.</ArticleTitle>
                  <JournalTitle>Trans Am Neurol Assoc</JournalTitle>
                  <VolumeID>104</VolumeID>
                  <FirstPage>25</FirstPage>
                  <LastPage>9</LastPage>
                  <Occurrence Type="PID">
                    <Handle>553424</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaL3M%2FotVOiuw%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Smith, K. J., W. I. McDonald, et al (1979). “Restoration of secure conduction by central demyelination.” Trans Am Neurol Assoc 104: 25–9.</BibUnstructured>
              </Citation>
              <Citation ID="CR21_5">
                <CitationNumber>21.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>S. G.</Initials>
                    <FamilyName>Waxman</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D. A.</Initials>
                    <FamilyName>Utzschneider</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>1994</Year>
                  <ArticleTitle Language="En">“Enhancement of action potential conduction following demyelination: experimental approaches to restoration of function in multiple sclerosis and spinal cord injury.</ArticleTitle>
                  <JournalTitle>Prog Brain Res</JournalTitle>
                  <VolumeID>100</VolumeID>
                  <FirstPage>233</FirstPage>
                  <LastPage>43</LastPage>
                  <Occurrence Type="PID">
                    <Handle>7938524</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0079-6123(08)60790-6</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaK2M%2FisVOjug%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Waxman, S. G., D. A. Utzschneider, et al (1994). “Enhancement of action potential conduction following demyelination: experimental approaches to restoration of function in multiple sclerosis and spinal cord injury.” Prog Brain Res 100: 233–43.</BibUnstructured>
              </Citation>
              <Citation ID="CR22_5">
                <CitationNumber>22.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>N. D.</Initials>
                    <FamilyName>Jeffery</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A. J.</Initials>
                    <FamilyName>Crang</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>1999</Year>
                  <ArticleTitle Language="En">“Behavioral consequences of oligodendrocyte progenitor cell transplantation into experimental demyelinating lesions in the rat spinal cord.</ArticleTitle>
                  <JournalTitle>Eur J Neurosci</JournalTitle>
                  <VolumeID>11</VolumeID>
                  <IssueID>5</IssueID>
                  <FirstPage>1508</FirstPage>
                  <LastPage>14</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10215903</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1046/j.1460-9568.1999.00564.x</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaK1M3jtl2nsw%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Jeffery, N. D., A. J. Crang, et al (1999). “Behavioral consequences of oligodendrocyte progenitor cell transplantation into experimental demyelinating lesions in the rat spinal cord.” Eur J Neurosci 11(5): 1508–14.</BibUnstructured>
              </Citation>
              <Citation ID="CR23_5">
                <CitationNumber>23.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>M. O.</Initials>
                    <FamilyName>Totoiu</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G. I.</Initials>
                    <FamilyName>Nistor</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">“Remyelination, axonal sparing, and locomotor recovery following transplantation of glial-committed progenitor cells into the MHV model of multiple sclerosis.</ArticleTitle>
                  <JournalTitle>Exp Neurol</JournalTitle>
                  <VolumeID>187</VolumeID>
                  <IssueID>2</IssueID>
                  <FirstPage>254</FirstPage>
                  <LastPage>65</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15144852</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/j.expneurol.2004.01.028</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXktV2lsro%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Totoiu, M. O., G. I. Nistor, et al (2004). “Remyelination, axonal sparing, and locomotor recovery following transplantation of glial-committed progenitor cells into the MHV model of multiple sclerosis.” Exp Neurol 187(2): 254–65.</BibUnstructured>
              </Citation>
              <Citation ID="CR24_5">
                <CitationNumber>24.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>H. S.</Initials>
                    <FamilyName>Keirstead</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G.</Initials>
                    <FamilyName>Nistor</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2005</Year>
                  <ArticleTitle Language="En">“Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants remyelinate and restore locomotion after spinal cord injury.</ArticleTitle>
                  <JournalTitle>J Neurosci</JournalTitle>
                  <VolumeID>25</VolumeID>
                  <IssueID>19</IssueID>
                  <FirstPage>4694</FirstPage>
                  <LastPage>705</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15888645</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1523/JNEUROSCI.0311-05.2005</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2MXksFalt70%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Keirstead, H. S., G. Nistor, et al (2005). “Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants remyelinate and restore locomotion after spinal cord injury.” J Neurosci 25(19): 4694–705.</BibUnstructured>
              </Citation>
              <Citation ID="CR25_5">
                <CitationNumber>25.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>B.</Initials>
                    <FamilyName>Kornek</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M. K.</Initials>
                    <FamilyName>Storch</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">“Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions.</ArticleTitle>
                  <JournalTitle>Am J Pathol</JournalTitle>
                  <VolumeID>157</VolumeID>
                  <IssueID>1</IssueID>
                  <FirstPage>267</FirstPage>
                  <LastPage>76</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10880396</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0002-9440(10)64537-3</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DC%2BD3czptVagsw%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Kornek, B., M. K. Storch, et al (2000). “Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions.” Am J Pathol 157(1): 267–76.</BibUnstructured>
              </Citation>
              <Citation ID="CR26_5">
                <CitationNumber>26.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>C.</Initials>
                    <FamilyName>Zhao</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S. P.</Initials>
                    <FamilyName>Fancy</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2005</Year>
                  <ArticleTitle Language="En">“Stem cells, progenitors and myelin repair.</ArticleTitle>
                  <JournalTitle>J Anat</JournalTitle>
                  <VolumeID>207</VolumeID>
                  <IssueID>3</IssueID>
                  <FirstPage>251</FirstPage>
                  <LastPage>8</LastPage>
                  <Occurrence Type="PID">
                    <Handle>16185249</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1111/j.1469-7580.2005.00456.x</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2MXhtFSnsbzN</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Zhao, C., S. P. Fancy, et al (2005). “Stem cells, progenitors and myelin repair.” J Anat 207(3): 251–8.</BibUnstructured>
              </Citation>
              <Citation ID="CR27_5">
                <CitationNumber>27.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>R. J.</Initials>
                    <FamilyName>Franklin</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S. A.</Initials>
                    <FamilyName>Bayley</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>1996</Year>
                  <ArticleTitle Language="En">“Transplanted CG4 cells (an oligodendrocyte progenitor cell line) survive, migrate, and contribute to repair of areas of demyelination in X-irradiated and damaged spinal cord but not in normal spinal cord.</ArticleTitle>
                  <JournalTitle>Exp Neurol</JournalTitle>
                  <VolumeID>137</VolumeID>
                  <IssueID>2</IssueID>
                  <FirstPage>263</FirstPage>
                  <LastPage>76</LastPage>
                  <Occurrence Type="PID">
                    <Handle>8635541</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1006/exnr.1996.0025</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaK287nvVSntQ%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Franklin, R. J., S. A. Bayley, et al (1996). “Transplanted CG4 cells (an oligodendrocyte progenitor cell line) survive, migrate, and contribute to repair of areas of demyelination in X-irradiated and damaged spinal cord but not in normal spinal cord.” Exp Neurol 137(2): 263–76.</BibUnstructured>
              </Citation>
              <Citation ID="CR28_5">
                <CitationNumber>28.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>R. J.</Initials>
                    <FamilyName>Franklin</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>W. F.</Initials>
                    <FamilyName>Blakemore</FamilyName>
                  </BibAuthorName>
                  <Year>1997</Year>
                  <ArticleTitle Language="En">“Transplanting oligodendrocyte progenitors into the adult CNS.</ArticleTitle>
                  <JournalTitle>J Anat</JournalTitle>
                  <VolumeID>190</VolumeID>
                  <IssueID>Pt 1</IssueID>
                  <FirstPage>23</FirstPage>
                  <LastPage>33</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9034879</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1046/j.1469-7580.1997.19010023.x</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Franklin, R. J. and W. F. Blakemore (1997). “Transplanting oligodendrocyte progenitors into the adult CNS.” J Anat 190(Pt 1): 23–33.</BibUnstructured>
              </Citation>
              <Citation ID="CR29_5">
                <CitationNumber>29.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>R. J.</Initials>
                    <FamilyName>Franklin</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J. M.</Initials>
                    <FamilyName>Gilson</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>1996</Year>
                  <ArticleTitle Language="En">“Schwann cell-like myelination following transplantation of an olfactory bulb-ensheathing cell line into areas of demyelination in the adult CNS.</ArticleTitle>
                  <JournalTitle>Glia</JournalTitle>
                  <VolumeID>17</VolumeID>
                  <IssueID>3</IssueID>
                  <FirstPage>217</FirstPage>
                  <LastPage>24</LastPage>
                  <Occurrence Type="PID">
                    <Handle>8840163</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1002/(SICI)1098-1136(199607)17:3&lt;217::AID-GLIA4&gt;3.0.CO;2-Y</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaK28vjslCrtQ%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Franklin, R. J., J. M. Gilson, et al (1996). “Schwann cell-like myelination following transplantation of an olfactory bulb-ensheathing cell line into areas of demyelination in the adult CNS.” Glia 17(3): 217–24.</BibUnstructured>
              </Citation>
              <Citation ID="CR30_5">
                <CitationNumber>30.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>M. T.</Initials>
                    <FamilyName>O’Leary</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>W. F.</Initials>
                    <FamilyName>Blakemore</FamilyName>
                  </BibAuthorName>
                  <Year>1997</Year>
                  <ArticleTitle Language="En">“Oligodendrocyte precursors survive poorly and do not migrate following transplantation into the normal adult central nervous system.</ArticleTitle>
                  <JournalTitle>J Neurosci Res</JournalTitle>
                  <VolumeID>48</VolumeID>
                  <IssueID>2</IssueID>
                  <FirstPage>159</FirstPage>
                  <LastPage>67</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9130144</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1002/(SICI)1097-4547(19970415)48:2&lt;159::AID-JNR8&gt;3.0.CO;2-B</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>O’Leary, M. T. and W. F. Blakemore (1997). “Oligodendrocyte precursors survive poorly and do not migrate following transplantation into the normal adult central nervous system.” J Neurosci Res 48(2): 159–67.</BibUnstructured>
              </Citation>
              <Citation ID="CR31_5">
                <CitationNumber>31.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>M. H.</Initials>
                    <FamilyName>Tuszynski</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>N.</Initials>
                    <FamilyName>Weidner</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>1998</Year>
                  <ArticleTitle Language="En">“Grafts of genetically modified Schwann cells to the spinal cord: survival, axon growth, and myelination.</ArticleTitle>
                  <JournalTitle>Cell Transplant</JournalTitle>
                  <VolumeID>7</VolumeID>
                  <IssueID>2</IssueID>
                  <FirstPage>187</FirstPage>
                  <LastPage>96</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9588600</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0963-6897(97)00166-8</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaK1c3kvVSitg%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Tuszynski, M. H., N. Weidner, et al (1998). “Grafts of genetically modified Schwann cells to the spinal cord: survival, axon growth, and myelination.” Cell Transplant 7(2): 187–96.</BibUnstructured>
              </Citation>
              <Citation ID="CR32_5">
                <CitationNumber>32.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>Y.</Initials>
                    <FamilyName>Iwashita</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J. W.</Initials>
                    <FamilyName>Fawcett</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">“Schwann cells transplanted into normal and X-irradiated adult white matter do not migrate extensively and show poor long-term survival.</ArticleTitle>
                  <JournalTitle>Exp Neurol</JournalTitle>
                  <VolumeID>164</VolumeID>
                  <IssueID>2</IssueID>
                  <FirstPage>292</FirstPage>
                  <LastPage>302</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10915568</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1006/exnr.2000.7440</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DC%2BD3cvht1Sgtw%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Iwashita, Y., J. W. Fawcett, et al (2000). “Schwann cells transplanted into normal and X-irradiated adult white matter do not migrate extensively and show poor long-term survival.” Exp Neurol 164(2): 292–302.</BibUnstructured>
              </Citation>
              <Citation ID="CR33_5">
                <CitationNumber>33.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>A.</Initials>
                    <FamilyName>Ramon-Cueto</FamilyName>
                  </BibAuthorName>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">“Olfactory ensheathing glia transplantation into the injured spinal cord.</ArticleTitle>
                  <JournalTitle>Prog Brain Res</JournalTitle>
                  <VolumeID>128</VolumeID>
                  <FirstPage>265</FirstPage>
                  <LastPage>72</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11105686</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0079-6123(00)28024-2</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DC%2BD3M%2FntVynsA%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Ramon-Cueto, A. (2000). “Olfactory ensheathing glia transplantation into the injured spinal cord.” Prog Brain Res 128: 265–72.</BibUnstructured>
              </Citation>
              <Citation ID="CR34_5">
                <CitationNumber>34.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>S.</Initials>
                    <FamilyName>Liu</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y.</Initials>
                    <FamilyName>Qu</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">“Embryonic stem cells differentiate into oligodendrocytes and myelinate in culture and after spinal cord transplantation.</ArticleTitle>
                  <JournalTitle>Proc Natl Acad Sci U S A</JournalTitle>
                  <VolumeID>97</VolumeID>
                  <IssueID>11</IssueID>
                  <FirstPage>6126</FirstPage>
                  <LastPage>31</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10823956</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1073/pnas.97.11.6126</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3cXjvFartbs%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Liu, S., Y. Qu, et al (2000). “Embryonic stem cells differentiate into oligodendrocytes and myelinate in culture and after spinal cord transplantation.” Proc Natl Acad Sci U S A 97(11): 6126–31.</BibUnstructured>
              </Citation>
              <Citation ID="CR35_5">
                <CitationNumber>35.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>Y.</Initials>
                    <FamilyName>Ogawa</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K.</Initials>
                    <FamilyName>Sawamoto</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">“Transplantation of in vitro-expanded fetal neural progenitor cells results in neurogenesis and functional recovery after spinal cord contusion injury in adult rats.</ArticleTitle>
                  <JournalTitle>J Neurosci Res</JournalTitle>
                  <VolumeID>69</VolumeID>
                  <IssueID>6</IssueID>
                  <FirstPage>925</FirstPage>
                  <LastPage>33</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12205685</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1002/jnr.10341</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XntFGnuro%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Ogawa, Y., K. Sawamoto, et al (2002). “Transplantation of in vitro-expanded fetal neural progenitor cells results in neurogenesis and functional recovery after spinal cord contusion injury in adult rats.” J Neurosci Res 69(6): 925–33.</BibUnstructured>
              </Citation>
              <Citation ID="CR36_5">
                <CitationNumber>36.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>T.</Initials>
                    <FamilyName>Ben-Hur</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>O.</Initials>
                    <FamilyName>Einstein</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">“Transplanted multipotential neural precursor cells migrate into the inflamed white matter in response to experimental autoimmune encephalomyelitis.</ArticleTitle>
                  <JournalTitle>Glia</JournalTitle>
                  <VolumeID>41</VolumeID>
                  <IssueID>1</IssueID>
                  <FirstPage>73</FirstPage>
                  <LastPage>80</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12465047</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1002/glia.10159</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Ben-Hur, T., O. Einstein, et al (2003). “Transplanted multipotential neural precursor cells migrate into the inflamed white matter in response to experimental autoimmune encephalomyelitis.” Glia 41(1): 73–80.</BibUnstructured>
              </Citation>
              <Citation ID="CR37_5">
                <CitationNumber>37.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>R.</Initials>
                    <FamilyName>Galli</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A.</Initials>
                    <FamilyName>Gritti</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">“Neural stem cells: an overview.</ArticleTitle>
                  <JournalTitle>Circ Res</JournalTitle>
                  <VolumeID>92</VolumeID>
                  <IssueID>6</IssueID>
                  <FirstPage>598</FirstPage>
                  <LastPage>608</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12676811</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1161/01.RES.0000065580.02404.F4</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXitlKntrs%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Galli, R., A. Gritti, et al (2003). “Neural stem cells: an overview.” Circ Res 92(6): 598–608.</BibUnstructured>
              </Citation>
              <Citation ID="CR38_5">
                <CitationNumber>38.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>A.</Initials>
                    <FamilyName>Iwanami</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S.</Initials>
                    <FamilyName>Kaneko</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2005</Year>
                  <ArticleTitle Language="En">“Transplantation of human neural stem cells for spinal cord injury in primates.</ArticleTitle>
                  <JournalTitle>J Neurosci Res</JournalTitle>
                  <VolumeID>80</VolumeID>
                  <IssueID>2</IssueID>
                  <FirstPage>182</FirstPage>
                  <LastPage>90</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15772979</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1002/jnr.20436</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2MXjtFajtr4%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Iwanami, A., S. Kaneko, et al (2005). “Transplantation of human neural stem cells for spinal cord injury in primates.” J Neurosci Res 80(2): 182–90.</BibUnstructured>
              </Citation>
              <Citation ID="CR39_5">
                <CitationNumber>39.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>G. I.</Initials>
                    <FamilyName>Nistor</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M. O.</Initials>
                    <FamilyName>Totoiu</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2005</Year>
                  <ArticleTitle Language="En">“Human embryonic stem cells differentiate into oligodendrocytes in high purity and myelinate after spinal cord transplantation.</ArticleTitle>
                  <JournalTitle>Glia</JournalTitle>
                  <VolumeID>49</VolumeID>
                  <IssueID>3</IssueID>
                  <FirstPage>385</FirstPage>
                  <LastPage>96</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15538751</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1002/glia.20127</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Nistor, G. I., M. O. Totoiu, et al (2005). “Human embryonic stem cells differentiate into oligodendrocytes in high purity and myelinate after spinal cord transplantation.” Glia 49(3): 385–96.</BibUnstructured>
              </Citation>
            </Bibliography>
          </ChapterBackmatter>
        </Chapter>
      </Part>
    </Book>
  </Series>
</Publisher>